Patent Publication Number: US-2011077154-A1

Title: Substituted pyridin-4-yl-methyl sulfonamides as fungicides

Description:
The present invention relates to compounds of formula I 
     
       
         
         
             
             
         
       
     
     wherein:
     Het is a fused-on 5- or 6-membered partially unsaturated or aromatic heterocycle wherein the ring member atoms of the fused-on heterocycle include besides carbon atoms 1, 2 or 3 heteroatoms selected from the group of N, O and S;   R f  is halogen, CN, NO 2 , C 1 -C 10 -haloalkyl, C 1 -C 10 -alkoxy, C 1 -C 10 -haloalkoxy, C 1 -C 10 -alkynyl or NR 1 R 2 ;
       R 1 ,R 2  are each independently of another hydrogen, C 1 -C 10 -alkyl or C(═O)—C 1 -C 6 -alkyl; and   
       m is 0, 1, 2, 3, 4 or 5, wherein R f  radicals are identical or different if m is 2, 3, 4 or 5;   R a  is halogen, CN, NH 2 , NO 2 , OH, SH, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy, C 1 -C 6 -alkylthio, C 1 -C 6 -haloalkylthio, C 1 -C 6 -alkylsulfinyl, C 1 -C 6 -haloalkylsulfinyl, C 1 -C 6 -alkylsulfonyl, C 1 -C 6 -haloalkylsulfonyl, C 1 -C 6 -alkylamino, di(C 1 -C 6 -alkyl)amino, C 2 -C 6 -alkenyl, C 2 -C 6 -haloalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -haloalkynyl, C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 3 -C 8 -cycloalkyl or C 1 -C 6 -alkyl-C 3 -C 8 -cycloalkyl; and   n is 0, 1 or 2, wherein R a  radicals are identical or different if n is 2;   R is hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 3 -C 8 -cycloalkyl, C 1 -C 6 -alkyl-C 3 -C 8 -cycloalkyl or benzyl wherein the phenyl moiety of benzyl is unsubstituted or carries 1, 2, 3, 4 or 5 substituents selected from the group consisting of CN, halogen, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy, C 1 -C 6 -alkoxycarbonyl and di(C 1 -C 6 -alkyl)aminocarbonyl;   A is phenylene or a 5- or 6-membered heteroarenediyl, wherein the ring member atoms of the 5-membered heteroarenediyl include besides carbon atoms 1, 2, 3 or 4 nitrogen atoms or 1 oxygen atom or 1, 2 or 3 nitrogen atoms and 1 sulfur or oxygen atom, and wherein the ring member atoms of the 6-membered heteroarenediyl include besides carbon atoms 2 or 3 nitrogen atoms, and wherein the aforementioned divalent radicals are unsubstituted or carry 1, 2, 3 or 4 identical or different groups R b :   R b  is halogen, CN, NO 2 , C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy, C 2 -C 6 -alkenyl, C 2 -C 6 -haloalkenyl, C 2 -C 6 -alkynyl, C 2 -C 6 -haloalkynyl, (C 1 -C 6 -alkyl)carbonyl, (C 1 -C 6 -alkoxy)carbonyl, C 1 -C 6 -alkylamino, di(C 1 -C 6 -alkyl)amino, (C 1 -C 6 -alkyl)aminocarbonyl and di(C 1 -C 6 -alkyl)aminocarbonyl; or
 
two radicals R b  that are bound to adjacent ring member atoms of the group A may form together with said ring member atoms a fused 5-, 6- or 7-membered saturated, partially unsaturated or aromatic cycle, which may be a carbocycle or heterocycle, wherein the ring member atoms of the fused heterocycle include besides carbon atoms 1, 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein the fused carbocycle or heterocycle is unsubstituted or carries 1, 2, 3 or 4 identical or different groups as defined for R b ;
   Y is a direct bond or a divalent group selected from —O—, —OCH 2 —, —CH 2 O—, —S—, —S(═O)—, —S(═O) 2 —, C 1 -C 6 -alkanediyl, —N(R n )— and —C(NOR n )—;
       R n  is hydrogen or C 1 -C 6 -alkyl;   
       R c  is halogen, CN, NO 2 , NH 2 , C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy, C 1 -C 6 -alkylamino, di(C 1 -C 6 -alkyl)amino, C 1 -C 6 -alkylthio, C 1 -C 6 -haloalkylthio, C 1 -C 6 -alkylsulfinyl, C 1 -C 6 -haloalkylsulfinyl, C 1 -C 6 -alkylsulfonyl, C 1 -C 6 -haloalkylsulfonyl, C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl, C 1 -C 6 -haloalkoxy-C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C(═O)R′, C(═NOR″)R′″, C 3 -C 8 -cycloalkyl, C 1 -C 6 -alkyl-C 3 -C 8 -cycloalkyl, phenyl, phenoxy, phenoxy-C 1 -C 6 -alkyl or a 5- or 6-membered heteroaryl, wherein the ring member atoms of the heteroaryl include besides carbon atoms 1, 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein the aforementioned cyclic radicals are unsubstituted or carry 1, 2, 3 or 4 identical or different substituents R d ; and   p is 0, 1, 2, 3, 4 or 5, wherein R c  radicals are identical or different if p is 2, 3, 4 or 5;
       R′ is hydrogen, NH 2 , C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl, C 1 -C 6 -alkoxy, C 1 -C 6 -alkoxy-C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy, C 1 -C 6 -alkylamino or di(C 1 -C 6 -alkyl)amino;   R″ is hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 2 -C 6 -alkenyl, C 2 -C 6 -alkynyl or C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl,   R′″ is hydrogen or C 1 -C 6 -alkyl;   R d  is halogen, CN, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy or C 1 -C 6 -haloalkoxy;
 
and/or two radicals R c  that are bound to adjacent ring member atoms of the phenyl ring may form together with said ring member atoms a fused 5-, 6- or 7-membered saturated, partially unsaturated or aromatic cycle, which may be a carbocycle or heterocycle, wherein the ring member atoms of the fused heterocycle include besides carbon atoms 1, 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein the fused cycle is unsubstituted or carries 1, 2, 3 or 4 identical or different radicals R e :
   R e  is halogen, CN, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy or C 1 -C 6 -haloalkoxy;
 
and the N-oxides and the agriculturally acceptable salts thereof.
   
       

     The invention also relates to processes and intermediates for preparing such compounds, to agrochemical compositions comprising a solvent or solid carrier and at least a compound of formula I or an N-oxide or an agriculturally acceptable salt thereof and their use for combating phytopathogenic fungi, and seed comprising a compound of formula I, or an N-oxide or an agriculturally acceptable salt thereof. 
     WO 05/033081 describes pyridin-4-ylmethyl sulfonamides and their use for combating phytopathogenic fungi. WO 06/097489 and WO 08/031,824 describe various pyridin-4-ylmethylamides of biphenyl sulfonic acid and their use as fungicides and insecticides, respectively. WO 07/093,599 and WO 08/022,937 describe pyridin-4-ylmethylamides of pyridiylsulfonic acid and thiophenesulfonic acid, respectively, and their use as fungicides. 
     The compounds according to the present invention differ from those described in WO 05/033081 and WO 06/097489 by having a pyridin-4-ylmethyl group carrying a fused-on heterocycle. 
     With respect to their fungicidal activity, the action of the known compounds is not always completely satisfactory. Based on this, it was an object of the present invention to provide compounds having improved action and/or a broadened activity spectrum against harmful fungi. This object is achieved by substituted pyridin-4-ylmethyl sulfonamides of formula I and its N-oxides and their salts, in particular the agriculturally acceptable salts, as defined herein. 
     The compounds I can be prepared by various routes in analogy to prior art processes known per se for preparing sulfonamides and, advantageously, by the synthesis shown in the following schemes and in the experimental part of this application. 
     A further aspect of the present invention relates to a process for preparing compounds I as defined before, which comprises reacting compounds II, wherein Het, R a , R f , m, n, and R are defined as above, under basic conditions with compounds III, wherein R c , p, A and Y are defined as above and L is a nucleophilic leaving group such as halogen, substituted phenoxy, N 3 , heterocyclyl or heterocyclyloxy, preferably pentafluorphenoxy, heterocyclyl such as imazolyl, pyrazolyl or triazolyl, or halogen such as chloro, fluoro or bromo, as shown below: 
     
       
         
         
             
             
         
       
     
     This reaction is usually carried out at temperatures of from −30 to 120° C., preferably from −10 to 100° C., in an inert organic solvent in the presence of a base. 
     Suitable solvents are aliphatic hydrocarbons, such as pentane, hexane, cyclohexane and petroleum ether, aromatic hydrocarbons, such as toluene, o-, m- and p-xylene, halogenated hydrocarbons, such as dichloromethane (DCM), chloroform and chlorobenzene, ethers, such as diethyl ether, diisopropyl ether, methyl tert.-butyl ether (MTBE), dioxane, anisole and tetrahydrofuran (THF), nitriles such as acetonitrile and propionitrile, ketones such as acetone, methyl ethyl ketone, diethyl ketone and tert.-butyl methyl ketone, and also dimethyl sulfoxide (DMSO), dimethyl formamide (DMF) and dimethyl acetamide, preferably THF, MTBE, dichloromethane, chloroform, acetonitrile, toluene or DMF, and also mixtures thereof. 
     Suitable bases are, in general, inorganic compounds such as alkali metal and alkaline earth metal hydroxides such as lithium hydroxide, sodium hydroxide, potassium hydroxide and calcium hydroxide, alkali metal and alkaline earth metal oxides such as lithium oxide, sodium oxide, calcium oxide and magnesium oxide, alkali metal and alkaline earth metal hydrides such as lithium hydride, sodium hydride, potassium hydride and calcium hydride, alkali metal and alkaline earth metal carbonates such as lithium carbonate, potassium carbonate and calcium carbonate, and also alkali metal bicarbonates such as sodium bicarbonate, moreover organic bases, e.g. tertiary amines such as trimethylamine, triethylamine, diisopropylethylamine and N-methylpiperidine (NMP), pyridine, substituted pyridines such as collidine, lutidine and 4-dimethylaminopyridine, and also bicyclic amines. Particular preference is given to triethylamine, pyridine, triethylamine and potassium carbonate. The bases are generally employed in catalytic amounts; however, they can also be used in equimolar amounts, in excess or, if appropriate, as solvent. The amount of base is typically 0.5 to 5 molar equivalents relative to 1 mole of compounds II. 
     The starting materials, i.e. compounds II and compounds III, are generally reacted with one another in equimolar amounts. In terms of yield it may be advantageous to employ an excess of compound II based on compound III. 
     Alternatively, compounds IV, wherein Het, R a , R f , m and n are as defined above and L′ is a leaving group such as methylsulfonyl, toluenesulfonyl, hydroxyl or a group as defined for L in formula III, preferably, methylsulfonyl, toluenesulfonyl or halogen such as chloro, bromo and iodo, can be reacted with compounds III.a, wherein R, R c , p, A and Y are as defined above, to obtain directly compounds I as shown below: 
     
       
         
         
             
             
         
       
     
     This reaction can be conducted under similar conditions as described for reacting compounds II with compounds III. Should other leaving groups L′ than hydroxy be desired, the hydroxy group can be effectively reacted to form the leaving group in question, e.g. in situ upon treatment with triphenylphosphine and diethylazodicarboxylate or diisopropylazodicarboxylate or a suitable substitute as described in Organ. Lett. 8, 5069-5072, 2006. 
     Alternatively, this reaction may also be carried out in two consecutive steps as shown below, wherein Het, R a , R c , R f , m, n, p, R, A, Y and L are defined as above: 
     
       
         
         
             
             
         
       
     
     Both of the abovementioned reaction steps can be conducted under similar conditions as described for reacting compounds II with compounds III. 
     Alternatively, this reaction may also be carried as shown below, wherein Het, R a , R c , R d , m, n, p, R, A, Y and L are defined as above: 
     
       
         
         
             
             
         
       
     
     Both of the abovementioned reaction steps can be conducted under similar conditions as described for reacting compounds II with compounds III. 
     Compounds VII may also be obtained by reacting compounds VIII, wherein A is as defined above and L 1  and L are leaving goups and have one of the meanings mentioned for L in formula III, preferably being L 1  and L different from each other, with compounds II as shown below: 
     
       
         
         
             
             
         
       
     
     This reaction can be conducted under similar conditions as described for reacting compounds II with compounds III. 
     Some compounds II are known from the literature (cf. Bioorg. Med. Chem. 15(7), 2759-2767, 2007; US 2007/129547; WO 07/64993), are commercially available or they can be prepared by reactions known in the art e.g. by treatment with ammonia or ammonium acetate in the presence or absence of a suitable iodide salt, such as NaI, KI or tetrabutylammonium iodide, in an analogous fashion to the one described in WO 07/69685. Alternatively, compounds II may be prepared starting from derivatives IV by treatment with a suitable phthalimide salt, preferably K +  or Na +  salt, followed by hydrazine, as illustrated in US 2007/129547. 
     Alternatively, compounds II, wherein R is hydrogen, can be prepared by reduction of the corresponding oximes IX.a, nitriles IX.b, or amides IX.c or by reductive amination of the corresponding aldehydes IX.d or ketones IX.e as described below. Appropriate methods therefore are known to those skilled in the art: 
     
       
         
         
             
             
         
       
     
     Methods suitable for the reduction of oximes IX.a, aldehydes IX.d or ketones IX.e to the corresponding compounds II have been described in the literature e.g. in March, J. “Advanced Organic Chemistry: Reactions, Mechanisms, and Structure” (Wiley &amp; Sons, New York, 4th ed., 1992, pp. 1218-1219). 
     Methods suitable for the reduction of nitriles IX.b to the corresponding compounds II have been described in the literature, e.g. in March, J. “Advanced Organic Chemistry: Reactions, Mechanisms, and Structure” (Wiley &amp; Sons, New York, 4th ed., 1992, 918-919). 
     Methods suitable for the reduction of amides IX.c to the corresponding compounds II have been described in the literature, e.g. in March, J. “Advanced Organic Chemistry: Reactions, Mechanisms, and Structure” (Wiley &amp; Sons, New York, 4th ed., 1992, 1212-1213). 
     The oximes IX.a can be prepared prepared by reactions known in the art, e.g. from either the respective aldehydes IX.d, ketones IX.e, or the methyl derivatives IX.f in analogy to methods described by Houben-Weyl, vol. 10/4, Thieme, Stuttgart, 1968; vol. 11/2, 1957; vol E5, 1985; J. Prakt. Chem./Chem. Ztg. 336(8), 695-697, 1994; Tetrahedron Lett. 42(39), 6815-6818, 2001; Heterocycles 29(9), 1741-1760, 1989; or Liebigs Ann. Chem. 737, 39-45, 1970. 
     The aldehydes IX.d can be synthesized from the corresponding methyl derivatives IX.f in analogy to J. Org. Chem. 51(4), 536-537, 1986, or from halogenated derivatives IX.g as shown in Eur. J. Org. Chem. 2003(8), 1576-1588, 2003; Tetrahedron Lett. 40(19), 3719-3722 1999; or Tetrahedron 55(41), 12149-12156, 1999. The ketones IX.e may be prepared by oxidation of the corresponding alcohols using standard agents, e.g. in analogy to the methods described in Synthesis 11, 881-884; or Heterocycles 71(4), 911-918. 
     The nitriles IX.b can be prepared in analogy to methods described in Heterocycles, 41(4), 675 (1995); Chem. Pharm. Bull., 21, 1927 et sqq. (1973); or J. Chem. Soc., 426 et sqq. (1942); e.g. from the corresponding halogenated derivatives IX.g by reaction with cyanides such as CuCN, NaCN or KCN or in analogy to the route described in Monatsh. Chem. 87, 526-536, (1956), e.g. from the corresponding halogenated derivatives IX.g by reaction with a trialkylamine to afford the trialkylammonium substituted derivatives, followed by reaction with suitable cyanation reagents such as organic or inorganic cyanides, e.g. tetraalkylammonium cyanides, NaCN or KCN. The compounds IX.g are commercially available or can be synthesized according to standard methods. 
     The amides IX.c can be prepared, e.g. from the corresponding carboxylic acid chlorides or anhydrides by reaction with ammonia, e.g. as described in March, J. “Advanced Organic Chemistry: Reactions, Mechanisms, and Structure” (Wiley &amp; Sons, New York, 3th edition, 1985, 370-371). 
     A further method to obtain compounds II is shown below, wherein PG is a suitable protection group that may be cleaved under acidic, basic or standard hydrogenation conditions such as defined below: 
     
       
         
         
             
             
         
       
     
     Protection of amino groups against reaction during one or more synthesis steps is a procedure well known and described in the art. Examples of suitable protection groups are those which are customarily used in organic synthesis, preferably t-butyloxycarbonyl, benzyloxycarbonyl, allyloxy-carbonyl, diformyl or phthaloyl. Further details on suitable protection groups and their cleavage may be found in Greene T. W., Wits P. G. “Protective groups in organic synthesis” (Wiley &amp; Sons, New York, 1999, 494 et sqq.). The hydrogenation of the nitriles IX.b can be advantegously performed in the presence of suitable catalysts, preferably Raney nickel or palladium-on-carbon, and protection reagents such as di-tert.-butyl dicarbonate, dibenzyl dicarbonate, benzyl chloroformate, to yield the N-protected compounds X. On treating with hydrogen chloride or with hydrogen bromide/glacial acetic acid or with trifluoroacetic acid/water mixtures, the compounds X can be deprotected to yield compounds II, wherein R is hydrogen. 
     Compounds IV, wherein L′ is halogen, preferably Cl or Br, may be synthesized under standard halogenation conditions, e.g. by treatment of the corresponding methyl derivative IX.f with halogenation reagents such as Cl 2 , Br 2 , N-chlorosuccinimide, N-bromosuccinimide or isocyanuric chloride in analogy to methods described in Bioorg. Med. Chem. 15(10), 3315-3320; 2007, Eur. J. Org. Chem. 4, 947-957, 2006; J. Med. Chem. 48(5), 1367-1383, 2005; or J. Org. Chem. 68(11), 4179-4188, 2003. 
     The condensed pyridine compounds XI 
     
       
         
         
             
             
         
       
     
     wherein R a , R f , m, n and Het are defined as above, can be prepared by various routes in analogy to prior art processes known per se and, advantageously, by the synthesis shown in the following schemes. 
     Compounds XI.a, wherein the condensed ring is [1,5]naphthyridine, can be prepared from 3-aminopyridines XII by reaction with glycerol as illustrated in J. Med. Chem. 2004, 47 (18), 4494 et sqq. and shown below: 
     
       
         
         
             
             
         
       
     
     Generally, the reaction is carried out at temperatures of from 0° C. to 200° C., preferably from 25° C. to 200° C., in an inert organic solvent in the presence of a strong Brønsted or Lewis acid. 
     Suitable solvents are aliphatic hydrocarbons such as pentane, hexane, cyclohexane and petrol ether, aromatic hydrocarbons such as toluene, o-, m- and p-xylene, halogenated hydrocarbons such as DCM, chloroform and chlorobenzene, ethers such as diethyl ether, diisopropyl ether, MTBE, dioxane, anisole and THF, nitriles such as acetonitrile and propionitrile, ketones, such as acetone, methyl ethyl ketone, diethyl ketone and tert.-butyl methyl ketone, alcohols such as methanol, ethanol, n-propanol, isopropanol, n-butanol and tert.-butanol, and also DMSO, DMF, dimethyl acetamide, NMP, N-ethyl-2-pyrrolidone (NEP) and acetic acid ethyl ester. It is also possible to use mixtures of the solvents mentioned. 
     Suitable acids and acidic catalysts are anorganic acids such as hydrofluoric acid, hydrochloric acid, hydrobromic acid, sulfuric acid and perchloric acid, Lewis acids such as boron trifluoride, aluminium trichloride, iron(III) chloride, tin(IV) chloride, titanium(IV) chloride and zinc(II) chloride, moreover organic acids such as formic acid, acetic acid, propionic acid, oxalic acid, toluenesulfonic acid, benzenesulfonic acid, camphorsulfonic acid, citric acid and trifluoroacetic acid. Particular preference is given to sulfuric acid and H 3 BO 3 .FeSO 4 .7H 2 O. 
     The acids are generally employed in catalytic amounts; however, they can also be used in equimolar amounts, in excess or, if appropriate, as solvent. The starting materials, are generally reacted with one another in equimolar amounts. 
     Compounds XI.b, wherein the condensed ring is 1H-[1,5]naphthyridin-2-one, can be prepared, from 2-halo-3-aminopyridines XII.a, wherein Hal is fluoride, chloride, bromide or iodide, especially fluoride or chloride, by reaction with acrylates (e.g. ethyl acrylate) as illustrated in Chem. Pharm. Bull. 1985, 33 (11), 4764 et sqq. and shown below. The resulting compounds XI.b may be further transformed to the corresponding chloride using POCl 3  and reacted with various nucleophiles: 
     
       
         
         
             
             
         
       
     
     Generally, the first reaction is carried out at temperatures of from 0° C. to 200° C., preferably from 25° C. to 200° C., in an inert organic solvent in the presence of a palladium catalyst and a phosphine ligand, such as palladium(II) acetate and tri-p-tolyl-phosphane. The second (ring-closing) step may be carried out under basic conditions at temperatures of from 0° C. to 200° C., preferably from 25° C. to 200° C., preferably in an inert organic solvent. 
     Suitable solvents are aliphatic hydrocarbons such as pentane, hexane, cyclohexane and petrol ether, aromatic hydrocarbons such as toluene, o-, m- and p-xylene, halogenated hydrocarbons such as DCM, chloroform and chlorobenzene, ethers such as diethyl ether, diisopropyl ether, MTBE, dioxane, anisole and THF, nitriles such as acetonitrile and propionitrile, ketones, such as acetone, methyl ethyl ketone, diethyl ketone and tert.-butyl methyl ketone, alcohols such as methanol, ethanol, n-propanol, isopropanol, n-butanol and tert.-butanol, and also DMSO, DMF, dimethyl acetamide, NMP, NEP and acetic acid ethyl ester. It is also possible to use mixtures of the solvents mentioned. 
     Suitable bases are, in general, inorganic compounds, such as alkali metal and alkaline earth metal hydroxides such as lithium hydroxide, sodium hydroxide, potassium hydroxide and calcium hydroxide, alkali metal and alkaline earth metal oxides such as lithium oxide, sodium oxide, potassium oxide and calcium oxide, alkali metal and alkaline earth metal phosphates such as lithium phosphate, sodium phosphate, potassium phosphate and calcium phosphate, alkali metal amides such as lithium amide, sodium amide and potassium amide, alkali metal and alkaline earth metal hydrides lithium hydride, sodium hydride, potassium hydride and calcium hydride, alkali metal and alkaline earth metal carbonates such as lithium carbonate, potassium carbonate and calcium carbonate, alkali metal bicarbonates such as sodium bicarbonate and potassium bicarbonate, moreover organic bases, for example tertiary amines such as trimethylamine, triethylamine, tributylamine, diisopropylethylamine and NMP, pyridine, substituted pyridines such as collidine, lutidine and 4-dimethylaminopyridine, and also bicyclic amines. Particular preference is given to alkali metal alkoxides, such as sodium and potassium methoxide, as well as sodium and potassium ethoxide. 
     The bases are generally employed in catalytic amounts; however, they can also be used in equimolar amounts, in excess or, if appropriate, as solvent. 
     The starting materials, are generally reacted with one another in equimolar amounts. 
     Compounds XI.c, wherein the condensed ring is 6H-[1,6]naphthyridin-5-one, may be prepared, e.g., from 2-halo-3-cyanopyridines XII.b by reaction with ethyne as illustrated in Chem. Pharm. Bull. 1985, 33 (2), 626 et sqq. and shown below: 
     
       
         
         
             
             
         
       
     
     Generally, the first reaction is carried out at temperatures from 0° C. to 200° C., preferably from 25° C. to 200° C., in an inert organic solvent in the presence of a palladium catalyst and a phosphine ligand, such as palladium(II) acetate and tri-p-tolyl-phosphane. The last (ring-closing) step may be carried out under basic conditions. 
     Suitable solvents are aliphatic hydrocarbons such as pentane, hexane, cyclohexane and petrol ether, aromatic hydrocarbons such as toluene, o-, m- and p-xylene, halogenated hydrocarbons such as dichloromethane (DCM), chloroform and chlorobenzene, ethers such as diethyl ether, diisopropyl ether, MTBE, dioxane, anisole and THF, nitriles such as acetonitrile and propionitrile, ketones such as acetone, methyl ethyl ketone, diethyl ketone and tert.-butyl methyl ketone, alcohols such as methanol, ethanol, n-propanol, isopropanol, n-butanol and tert.-butanol, and also DMSO, DMF, dimethyl acetamide, NMP, NEP and acetic acid ethyl ester, it being possible to use mixtures of these solvents. 
     Suitable bases are, in general, inorganic compounds, such as alkali metal and alkaline earth metal hydroxides such as lithium hydroxide, sodium hydroxide, potassium hydroxide and calcium hydroxide, alkali metal and alkaline earth metal oxides such as lithium oxide, sodium oxide, potassium oxide and calcium oxide, alkali metal and alkaline earth metal phosphates such as lithium phosphate, sodium phosphate, potassium phosphate and calcium phosphate, alkali metal amides such as lithium amide, sodium amide and potassium amide, alkali metal and alkaline earth metal hydrides lithium hydride, sodium hydride, potassium hydride and calcium hydride, alkali metal and alkaline earth metal carbonates such as lithium carbonate, potassium carbonate and calcium carbonate, alkali metal bicarbonates such as sodium bicarbonate and potassium bicarbonate, moreover organic bases, for example tertiary amines such as trimethylamine, triethylamine, tributylamine, diisopropylethylamine and NMP, pyridine, substituted pyridines such as collidine, lutidine and 4-dimethylaminopyridine, and also bicyclic amines. Particular preference is given to alkali metal alkoxides, such as sodium and potassium methoxide, as well as sodium and potassium ethoxide. 
     The bases are generally employed in catalytic amounts; however, they can also be used in equimolar amounts, in excess or, if appropriate, as solvent. The starting materials, are generally reacted with one another in equimolar amounts. 
     Compounds XI.d, wherein the condensed ring is [1,8]naphthyridine, can be prepared from suitable protected 2-aminopyridines XII.c, wherein PG is as defined above, by reaction with dialkylamino propenals as illustrated in Synlett 2006, 3, 379 et sqq. and shown below: 
     
       
         
         
             
             
         
       
     
     Generally, the first reaction is carried out at temperatures of from about −80° C. to 25° C., preferably from about −80° C. to 0° C., in an inert organic solvent in the presence of an organolithium base such as lithium diisopropylamide, n-butyl lithium, sec-butyl lithium or tert-butyl lithium. 
     The second (ring-closing) step is may be performed under acidic conditions at temperatures of from about 0° C. to 200° C., preferably from 25° C. to 200° C., in an inert organic solvent. 
     Suitable solvents are aliphatic hydrocarbons such as pentane, hexane, cyclohexane and petrol ether, aromatic hydrocarbons such as toluene, o-, m- and p-xylene, halogenated hydrocarbons such as DCM, chloroform and chlorobenzene, ethers such as diethyl ether, diisopropyl ether, MTBE, dioxane, anisole and THF, nitriles such as acetonitrile and propionitrile, ketones, such as acetone, methyl ethyl ketone, diethyl ketone and tert.-butyl methyl ketone, alcohols such as methanol, ethanol, n-propanol, isopropanol, n-butanol and tert.-butanol, and also DMSO, DMF, dimethyl acetamide, NMP, NEP and acetic acid ethyl ester, 
     Suitable acids and acidic catalysts for the ring-closing step are anorganic acids such as hydrofluoric acid, hydrochloric acid, hydrobromic acid, sulfuric acid and perchloric acid, Lewis acids such as boron trifluoride, aluminium trichloride, iron(III) chloride, tin(IV) chloride, titanium(IV) chloride and zinc(II) chloride, moreover organic acids such as formic acid, acetic acid, propionic acid, oxalic acid, toluenesulfonic acid, benzenesulfonic acid, camphorsulfonic acid, citric acid and trifluoroacetic acid. 
     The bases and acids are generally employed in catalytic amounts; however, they can also be used in equimolar amounts, in excess or, if appropriate, as solvent. 
     The starting materials, are generally reacted with one another in equimolar amounts. 
     Compounds XI.e, wherein the condensed ring is pyrido[2,3-d]pyrimidine and R d  is as defined above, can be prepared, for example, from 2-halo-3-carbaldehydepyridines XII.d, wherein Hal is as defined above, by reaction with amidines in the presence of an acid or a base as illustrated in J. Org. Chem. 1964, 29(10), 2903 et sqq. and shown below: 
     
       
         
         
             
             
         
       
     
     Generally, the reaction is carried out at temperatures from 0° C. to 200° C., preferably from 25° C. to 200° C., in an inert organic solvent in the presence of a base or an acid. 
     Suitable solvents are aliphatic hydrocarbons such as pentane, hexane, cyclohexane and petrol ether, aromatic hydrocarbons such as toluene, o-, m- and p-xylene, halogenated hydrocarbons such as DCM, chloroform and chlorobenzene, ethers such as diethyl ether, diisopropyl ether, MTBE, dioxane, anisole and THF, nitriles such as acetonitrile and propionitrile, ketones, such as acetone, methyl ethyl ketone, diethyl ketone and tert.-butyl methyl ketone, alcohols such as methanol, ethanol, n-propanol, isopropanol, n-butanol and tert.-butanol, and also DMSO, DMF, dimethyl acetamide, NMP, NEP and acetic acid ethyl ester, it being possible to use mixtures of these solvents. 
     Suitable bases are, in general, inorganic compounds, such as alkali metal and alkaline earth metal hydroxides such as lithium hydroxide, sodium hydroxide, potassium hydroxide and calcium hydroxide, alkali metal and alkaline earth metal oxides such as lithium oxide, sodium oxide, potassium oxide and calcium oxide, alkali metal and alkaline earth metal phosphates such as lithium phosphate, sodium phosphate, potassium phosphate and calcium phosphate, alkali metal amides such as lithium amide, sodium amide and potassium amide, alkali metal and alkaline earth metal hydrides lithium hydride, sodium hydride, potassium hydride and calcium hydride, alkali metal and alkaline earth metal carbonates such as lithium carbonate, potassium carbonate and calcium carbonate, alkali metal bicarbonates such as sodium bicarbonate and potassium bicarbonate, moreover organic bases, for example tertiary amines such as trimethylamine, triethylamine, tributylamine, diisopropylethylamine and N-methyl-2-pyrrolidone (NMP), pyridine, substituted pyridines such as collidine, lutidine and 4-dimethylaminopyridine, and also bicyclic amines. 
     The bases are generally employed in catalytic amounts; however, they can also be used in equimolar amounts, in excess or, if appropriate, as solvent. 
     Suitable acids and acidic catalysts are anorganic acids such as hydrofluoric acid, hydrochloric acid, hydrobromic acid, sulfuric acid and perchioric acid, Lewis acids such as boron trifluoride, aluminium trichloride, iron(III) chloride, tin(IV) chloride, titanium(IV) chloride and zinc(II) chloride, moreover organic acids such as formic acid, acetic acid, propionic acid, oxalic acid, toluenesulfonic acid, benzenesulfonic acid, camphorsulfonic acid, citric acid and trifluoroacetic acid. 
     The acids are generally employed in catalytic amounts; however, they can also be used in equimolar amounts, in excess or, if appropriate, as solvent. 
     The starting materials, are generally reacted with one another in equimolar amounts. 
     Alternatively, compounds XI.e, can also be prepared, from 2-amino-3-methylamino-pyridines XII.e by reaction with 1,1,1-trialkoxyalkanes, wherein R′ is C 1 -C 10 -alkyl, in the presence of an acid or base as illustrated in J. Org. Chem. 1964, 29(10), 2903 et sqq. and shown below: 
     
       
         
         
             
             
         
       
     
     This reaction can be conducted under similar conditions as described for reacting compounds XII.d with amidines. 
     Compounds XI.f, wherein the condensed ring is pyrido[2,3-b]pyrazine, can be prepared, for example, from 2,3-diaminopyridines XII.f by reaction with glyoxal or a suitable derivative of the latter in the presence of an acid or a base as illustrated in Can. J. Chem. 1988, 66 (6), 1500 et sqq. and shown below: 
     
       
         
         
             
             
         
       
     
     This reaction can be conducted under similar conditions as described for reacting compounds XII.d with amidines. 
     Compounds XI.g, wherein the condensed ring is 1H-pyrrolo[2,3-b]pyridine and R f  is as defined above, preferably hydrogen or C 1 -C 10 -alkyl, can be prepared, for example, from 2-aminopyrroles XIII, wherein R f  is as defined above, by reaction with 1,3-diketones, wherein R a  is as defined above, preferably hydrogen or C 1 -C 10 -alkyl, in the presence of an acid or a base as illustrated in J. Chem. Soc. Perkin Trans. 11975, 19, 1920 et sqq. and shown below: 
     
       
         
         
             
             
         
       
     
     This reaction can be conducted under similar conditions as described for reacting compounds XII.d with amidines. 
     Analogous routes may be employed to access to compounds XI, wherein the condensed ring is furo[2,3-b]pyridine or thieno[2,3-b]pyridine. 
     Compounds XI.h, wherein the condensed ring is 1H-pyrrolo[3,2-b]pyridine and R f  is as defined above, preferably hydrogen or C 1 -C 10 -alkyl, can be prepared, for example, from 2-(2,2-dialkoxyethyl)-3-aminopyridines XII.g, wherein R f  is as defined above preferably hydrogen or C 1 -C 10 -alkyl, and R′ is C 1 -C 10 -alkyl, in the presence of a base or an acid as illustrated in Chem. Pharm. Bull. 1986, 34 (6), 2362 et sqq. and shown below: 
     
       
         
         
             
             
         
       
     
     This reaction can be conducted under similar conditions as described for reacting compounds XII.d with amidines. 
     Analogous routes may be employed to access to compounds XI, wherein the condensed ring isfuro[3,2-b]pyridine or thieno[3,2-b]pyridine. Compounds XI.j, wherein the coondenes ring is 1H-imidazo[4,5-b]pyridine, can be prepared, for example, from 1,4-diamino imidazoles XIV by reaction with 1,3-diketones as illustrated in J. Het. Chem. 1983, 20 (4), 1015 et sqq. and shown below: 
     
       
         
         
             
             
         
       
     
     This reaction can be conducted under similar conditions as described for reacting compounds XII.d with amidines. 
     Analogous routes may be employed to access to compounds XI, wherein the condensed ring is 3H-imidazo[4,5-b]pyridine, thiazolo[4,5-b]pyridine, oxazolo[4,5-b]pyridine, thiazolo[5,4-b]pyridine or oxazolo[5,4-b]pyridine. 
     Compounds XI.k, wherein the condensed ring is 2,2-dimethyl-[1,3]dioxolo[4,5-b]pyridine, can be prepared, for example, from 1,4-dihydro-pyridine-2,3-diones XV by reaction with acetone or 2,2-dimethoxy-propane as illustrated in J. Het. Chem. 1983, 20 (3), 703 et sqq. and Bioorg. Med. Chem. Lett. 2003, 13 (22), 4133 et sqq., respectively and shown below: 
     
       
         
         
             
             
         
       
     
     Generally, the reaction is carried out at temperatures of from 0° C. to 200° C., preferably from 25° C. to 200° C., in an inert organic solvent in the presence of an acid. 
     Suitable solvents are aliphatic hydrocarbons such as pentane, hexane, cyclohexane and petrol ether, aromatic hydrocarbons such as toluene, o-, m- and p-xylene, halogenated hydrocarbons such as DCM, chloroform and chlorobenzene, ethers such as diethyl ether, diisopropyl ether, MTBE, dioxane, anisole and THF, nitriles such as acetonitrile and propionitrile, ketones, such as acetone, methyl ethyl ketone, diethyl ketone and tert.-butyl methyl ketone, alcohols such as methanol, ethanol, n-propanol, isopropanol, n-butanol and tert.-butanol, and also DMSO, DMF, dimethyl acetamide, NMP, NEP and acetic acid ethyl ester, it being possible to use mixtures of these solvents. 
     Suitable acids and acidic catalysts are anorganic acids such as hydrofluoric acid, hydrochloric acid, hydrobromic acid, sulfuric acid and perchloric acid, Lewis acids such as boron trifluoride, aluminium trichloride, iron(III) chloride, tin(IV) chloride, titanium(IV) chloride and zinc(II) chloride, moreover organic acids such as formic acid, acetic acid, propionic acid, oxalic acid, toluenesulfonic acid, benzenesulfonic acid, camphorsulfonic acid, citric acid and trifluoroacetic acid. 
     The acids are generally employed in catalytic amounts; however, they can also be used in equimolar amounts, in excess or, if appropriate, as solvent. 
     The starting materials, are generally reacted with one another in equimolar amounts. 
     Compounds XI.m, wherein the condensed ring is 2,3-dihydro-[1,4]dioxino[2,3-b]pyridine, can be prepared, for example, from protected 2-halo-3-hydroxy-pyridines XII.h, wherein Hal is fluoride, chloride, bromide or iodide, especially fluoride or chloride and PG is a suitable protection group such as benzyl, trimethylsilyl, triisopropylsilyl, tertbytyldimethylsilyl, by reaction with a suitably protected 1,2-diol, wherein PG is a suitable protection group such as the ones described earlier, followed by deprotection and a ring-closing step as illustrated in Heterocycles 1994, 38 (6), 1355 et sqq. and shown below: 
     
       
         
         
             
             
         
       
     
     Generally, the first reaction is carried out at temperatures of from 0° C. to 200° C., preferably from 25° C. to 200° C., in an inert organic solvent in the presence of a base. The ring-closing step may be performed under acidic or basic conditions. 
     Suitable solvents are aliphatic hydrocarbons such as pentane, hexane, cyclohexane and petrol ether, aromatic hydrocarbons such as toluene, o-, m- and p-xylene, halogenated hydrocarbons such as DCM, chloroform and chlorobenzene, ethers such as diethyl ether, diisopropyl ether, MTBE, dioxane, anisole and THF, nitriles such as acetonitrile and propionitrile, ketones, such as acetone, methyl ethyl ketone, diethyl ketone and tert.-butyl methyl ketone, alcohols such as methanol, ethanol, n-propanol, isopropanol, n-butanol and tert.-butanol, and also DMSO, DMF, dimethyl acetamide, NMP, NEP and acetic acid ethyl ester, it being possible to use mixtures of these solvents. 
     Suitable bases are, in general, inorganic compounds, such as alkali metal and alkaline earth metal hydroxides such as lithium hydroxide, sodium hydroxide, potassium hydroxide and calcium hydroxide, alkali metal and alkaline earth metal oxides such as lithium oxide, sodium oxide, potassium oxide and calcium oxide, alkali metal and alkaline earth metal phosphates such as lithium phosphate, sodium phosphate, potassium phosphate and calcium phosphate, alkali metal amides such as lithium amide, sodium amide and potassium amide, alkali metal and alkaline earth metal hydrides lithium hydride, sodium hydride, potassium ydride and calcium hydride, alkali metal and alkaline earth metal carbonates such as lithium carbonate, potassium carbonate and calcium carbonate, alkali metal bicarbonates such as sodium bicarbonate and potassium bicarbonate, moreover organic bases, for example tertiary amines such as trimethylamine, triethylamine, tributylamine, diisopropylethylamine and NMP, pyridine, substituted pyridines such as collidine, lutidine and 4-dimethylaminopyridine, and also bicyclic amines. 
     The bases are generally employed in catalytic amounts; however, they can also be used in equimolar amounts, in excess or, if appropriate, as solvent. 
     Suitable acids and acidic catalysts are anorganic acids such as hydrofluoric acid, hydrochloric acid, hydrobromic acid, sulfuric acid and perchloric acid, Lewis acids such as wie boron trifluoride, aluminium trichloride, iron(III) chloride, tin(IV) chloride, titanium(IV) chloride and zinc(II) chloride, moreover organic acids such as formic acid, acetic acid, propionic acid, oxalic acid, toluenesulfonic acid, benzenesulfonic acid, camphorsulfonic acid, citric acid and trifluoroacetic acid. 
     The acids are generally employed in catalytic amounts; however, they can also be used in equimolar amounts, in excess or, if appropriate, as solvent. 
     The starting materials, are generally reacted with one another in equimolar amounts. 
     Compounds XI.n, wherein the condensed ring is 2,3-dihydro-furo[2,3-b]pyridine, can be prepared, for example, from 3-(2-hydroxy-ethyl)-pyridin-2-ols XII.j in the presence of an acid as illustrated in Heterocycles 1979, 12 (4), 493 et sqq. and shown below: 
     
       
         
         
             
             
         
       
     
     This reaction can be conducted under similar conditions as described for reacting compounds XV with acetone or 2,2-dimethoxy-propane. 
     Analogous routes may be employed to access to compounds XI, wherein the condensed ring is 2,3-dihydro-furo[3,2-b]pyridine, 3,4-dihydro-2H-pyrano[2,3-b]pyridine or 3,4-dihydro-2H-pyrano[3,2-b]pyridine. 
     Compounds XI.n can also be prepared, for example, from 3-(2-halo-ethyl)-pyridyl-2-ols XII.k, wherein Hal is fluoride, chloride, bromide or iodide, especially bromide or iodide, in the presence of a base as illustrated in J. Het. Chem. 1975, 12 (2), 247 et sqq. and Chem. Pharm. Bull. 1982, 30 (2), 552 et sqq. and shown below: 
     
       
         
         
             
             
         
       
     
     Generally, the first reaction is carried out at temperatures of from 0° C. to 200° C., preferably from 25° C. to 200° C., in an inert organic solvent in the presence of a base. 
     Suitable solvents are aliphatic hydrocarbons such as pentane, hexane, cyclohexane and petrol ether, aromatic hydrocarbons such as toluene, o-, m- and p-xylene, halogenated hydrocarbons such as DCM, chloroform and chlorobenzene, ethers such as diethyl ether, diisopropyl ether, MTBE, dioxane, anisole and THF, nitriles such as acetonitrile and propionitrile, ketones, such as acetone, methyl ethyl ketone, diethyl ketone and tert.-butyl methyl ketone, alcohols such as methanol, ethanol, n-propanol, isopropanol, n-butanol and tert.-butanol, and also DMSO, DMF, dimethyl acetamide, NMP, NEP and acetic acid ethyl ester, it being possible to use mixtures of these solvents. 
     Suitable bases are, in general, inorganic compounds, such as alkali metal and alkaline earth metal hydroxides such as lithium hydroxide, sodium hydroxide, potassium hydroxide and calcium hydroxide, alkali metal and alkaline earth metal oxides such as lithium oxide, sodium oxide, potassium oxide and calcium oxide, alkali metal and alkaline earth metal phosphates such as lithium phosphate, sodium phosphate, potassium phosphate and calcium phosphate, alkali metal amides such as lithium amide, sodium amide and potassium amide, alkali metal and alkaline earth metal hydrides lithium hydride, sodium hydride, potassium ydride and calcium hydride, alkali metal and alkaline earth metal carbonates such as lithium carbonate, potassium carbonate and calcium carbonate, alkali metal bicarbonates such as sodium bicarbonate and potassium bicarbonate, moreover organic bases, for example tertiary amines such as trimethylamine, triethylamine, tributylamine, diisopropylethylamine and NMP, pyridine, substituted pyridines such as collidine, lutidine and 4 dimethylaminopyridine, and also bicyclic amines. 
     The bases are generally employed in catalytic amounts; however, they can also be used in equimolar amounts, in excess or, if appropriate, as solvent. 
     Suitable acids and acidic catalysts are anorganic acids such as hydrofluoric acid, hydrochloric acid, hydrobromic acid, sulfuric acid and perchloric acid, Lewis acids such as wie boron trifluoride, aluminium trichloride, iron(III) chloride, tin(IV) chloride, titanium(IV) chloride and zinc(II) chloride, moreover organic acids such as formic acid, acetic acid, propionic acid, oxalic acid, toluenesulfonic acid, benzenesulfonic acid, camphorsulfonic acid, citric acid and trifluoroacetic acid. 
     The acids are generally employed in catalytic amounts; however, they can also be used in equimolar amounts, in excess or, if appropriate, as solvent. 
     The starting materials, are generally reacted with one another in equimolar amounts. 
     Alternatively, compounds XI.n, for example, from 2-(2-halo-pyridin-3-yl)-ethanols XII.m, wherein Hal is fluoride, chloride, bromide or iodide, especially fluoride or chloride in the presence of a base as illustrated in J. Am. Soc. 1969, 91 (23), 6464 et sqq. and J. Het. Chem. 1987, 24 (3), 725 et sqq. and shown below: 
     
       
         
         
             
             
         
       
     
     This reaction can be conducted under similar conditions as described for reacting compounds XII.k to obtain compounds XI.n. 
     If individual compounds II, IV and IX cannot be obtained by the routes described above, they can be prepared by derivatization of compounds XI. 
     Compounds IV, wherein L′ is methylsulfonyl or toluenesulfonyl, may be prepared under standard conditions by reacting the corresponding alcohol with methanesulfonic anhydride or trifluoromethanesulfonic anhydride, respectively, in analogy to methods described in J. Org. Chem. 50, 165-2170, 1985; or J. Chem. Soc. Perkin Trans. 1: Org. Bioorg. Chem. 12, 2887-2894, 1980. 
     The group R may be present in compounds II or may be introduced at a later stage as shown below by standard conditions in analogy to Coll. Czechoslovak. Chem. Comm. 40(4), 1193-1198, 1975 or J. Med. Chem. 19(12), 1409-1416, 1991, upon reaction of compounds I, wherein R is hydrogen, with suitable compounds XVI, wherein the R and the leaving group L are as defined above and which compounds XVI are known in the art: 
     
       
         
         
             
             
         
       
     
     Compounds III and its derivatives III.a and III.b are known in the art and can be prepared in analogy to methods described in the European patent application 08101694.1. 
     If individual compounds I cannot be obtained by the routes described above, they can be prepared by derivatization of other compounds I. 
     The N-oxides may be prepared from the compounds I according to conventional oxidation methods, e.g. by treating compounds I with an organic peracid such as metachloroperbenzoic acid (cf. WO 03/64572 or J. Med. Chem. 38(11), 1892-903, 1995); or with inorganic oxidizing agents such as hydrogen peroxide (cf. J. Heterocyc. Chem. 18(7), 1305-1308, 1981) or oxone (cf. J. Am. Chem. Soc. 123(25), 5962-5973, 2001). The oxidation may lead to pure mono-N-oxides or to a mixture of different N-oxides, which can be separated by conventional methods such as chromatography. 
     If the synthesis yields mixtures of isomers, a separation is generally not necessarily required since in some cases the individual isomers can be interconverted during workup for use or during application (e.g. under the action of light, acids or bases). Such conversions may also take place after use, e.g. in the treatment of plants in the treated plant, or in the harmful fungus to be controlled. 
     The term “compounds I” refers to compounds of formula I. Likewise, this terminology applies to all sub-formulae, e.g. “compounds I.2” refers to compounds of formula I.2 or “compounds II” refers to compounds of formula II. In the definitions of the variables given above, collective terms are used which are generally representative for the substituents in question. The term “C n -C m ” indicates the number of carbon atoms possible in each case in the substituent or substituent moiety in question. 
     The term “halogen” refers to fluorine, chlorine, bromine and iodine. 
     The term “C 1 -C 6 -alkyl” refers to a straight-chained or branched saturated hydrocarbon group having 1 to 6 carbon atoms, e.g. methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl and 1-ethyl-2-methylpropyl. Likewise, the term “C 1 -C 4 -alkyl” refers to a straight-chained or branched alkyl group having 1 to 4 carbon atoms. 
     The term “C 1 -C 4 -haloalkyl” refers to a straight-chained or branched alkyl group having 1 to 4 carbon atoms, wherein some or all of the hydrogen atoms in these groups may be replaced by halogen atoms, e.g. chloromethyl, bromomethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 1-chloroethyl, 1-bromoethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl and pentafluoroethyl, 2-fluoropropyl, 3-fluoropropyl, 2,2-difluoropropyl, 2,3-difluoropropyl, 2-chloropropyl, 3-chloropropyl, 2,3-dichloropropyl, 2-bromopropyl, 3-bromopropyl, 3,3,3-trifluoropropyl, 3,3,3-trichloropropyl, CH 2 —C 2 F 5 , CF 2 —C 2 F 5 , CF(CF 3 ) 2 , 1-(fluoromethyl)-2-fluoroethyl, 1-(chloromethyl)-2-chloroethyl, 1-(bromomethyl)-2-bromoethyl, 4-fluorobutyl, 4-chlorobutyl, 4-bromobutyl or nonafluorobutyl. Likewise, the term “C 1 -C 6 -haloalkyl” refers to a straight-chained or branched alkyl group having 1 to 6 carbon atoms, wherein some or all of the hydrogen atoms in these groups may be replaced by halogen atoms. 
     The term “C 1 -C 6 -alkoxy” refers to a straight-chain or branched alkyl group having 1 to 4 carbon atoms which is bonded via an oxygen, at any position in the alkyl group, e.g. OCH 3 , OCH 2 CH 3 , O(CH 2 ) 2 CH 3 , 1-methylethoxy, O(CH 2 ) 3 CH 3 , 1-methyl propoxy, 2-methylpropoxy or 1,1-dimethylethoxy, O(CH 2 ) 4 —CH 3  or O(CH 2 ) 5 CH 3 . Likewise, the term “C 1 -C 4 -alkoxy” refers to a straight-chain or branched alkyl group having 1 to 4 carbon atoms which is bonded via an oxygen, at any position in the alkyl group. 
     The term “C 1 -C 4 -haloalkoxy” refers to a C 1 -C 4 -alkoxy group, wherein some or all of the hydrogen atoms may be replaced by halogen atoms as mentioned above, e.g. OCH 2 F, OCHF 2 , OCF 3 , OCH 2 Cl, OCHCl 2 , OCCl 3 , chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 2-fluoroethoxy, 2-chloroethoxy, 2-bromoethoxy, 2-iodoethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro-2-fluoroethoxy, 2,2,2-trichloro ethoxy, OC 2 F 5 , 2-fluoropropoxy, 3-fluoropropoxy, 2,2-difluoropropoxy, 2,3-difluoro propoxy, 2-chloropropoxy, 3-chloropropoxy, 2,3-dichloropropoxy, 2-bromo propoxy, 3-bromopropoxy, 3,3,3-trifluoropropoxy, 3,3,3-trichloropropoxy, OCH 2 —C 2 F 5 , OCF 2 —C 2 F 5 , 1-difluoromethyl-2-fluoroethoxy, 1-dichloromethyl-2-chloroethoxy, 1-dibromomethyl-2-bromo ethoxy, 4-fluorobutoxy, 4-chlorobutoxy, 4-bromobutoxy or nonafluorobutoxy. Likewise, the term “C 1 -C 6 -haloalkoxy” refers to a C 1 -C 6 -alkoxy group, wherein some or all of the hydrogen atoms may be replaced by halogen atoms. 
     The term “C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl” refers to alkyl having 1 to 4 carbon atoms, wherein one hydrogen atom of the alkyl radical is replaced by a C 1 -C 4 -alkoxy group. Likewise, the term “C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl” refers to alkyl having 1 to 6 carbon atoms, wherein one hydrogen atom of the alkyl radical is replaced by a C 1 -C 6 -alkoxy group. 
     The term “C 1 -C 4 -haloalkoxy-C 1 -C 4 -alkyl” refers to alkyl having 1 to 4 carbon atoms, wherein one hydrogen atom of the alkyl radical is replaced by a C 1 -C 4 -haloalkoxy group. Likewise, the term “C 1 -C 6 -haloalkoxy-C 1 -C 6 -alkyl” refers to alkyl having 1 to 6 carbon atoms, wherein one hydrogen atom of the alkyl radical is replaced by a C 1 -C 6 -alkoxy group. 
     The term “C 1 -C 6 -alkoxy-C 1 -C 6 -alkoxy” refers to an C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl group, which is bonded via an oxygen atom to the remainder of the molecule. 
     The term “C 1 -C 4 -alkylthio” as used herein refers to straight-chain or branched alkyl groups having 1 to 4 carbon atoms bonded via a sulfur atom, at any position in the alkyl group, e.g. methylthio, ethylthio, propylthio, isopropylthio, and n-butylthio. Likewise, the term “C 1 -C 6 -alkylthio” as used herein refers to straight-chain or branched alkyl groups having 1 to 6 carbon atoms bonded via a sulfur atom. Accordingly, the terms “C 1 -C 4 -haloalkylthio” and “C 1 -C 6 -haloalkylthio” refer to straight-chain or branched haloalkyl groups having 1 to 4 or 1 to 6 carbon atoms bonded through a sulfur atom, at any position in the haloalkyl group. 
     The terms “C 1 -C 4 -alkylsulfinyl” and “C 1 -C 6 -alkylsulfinyl”, respectively refer to straight-chain or branched alkyl groups having 1 to 4 or 1 to 6 carbon atoms, respectively, bonded through a —S(═O)— moiety, at any position in the alkyl group, e.g. methylsulfinyl and ethylsulfinyl, and the like. Accordingly, the terms “C 1 -C 4 -haloalkylsulfinyl” and “C 1 -C 6 -haloalkylsulfinyl”, respectively, refer to straight-chain or branched haloalkyl groups having 1 to 4 and 1 to 6 carbon atoms, respectively, bonded through a —S(═O)— moiety, at any position in the haloalkyl group. 
     The terms “C 1 -C 4 -alkylsulfonyl” and “C 1 -C 6 -alkylsulfonyl”, respectively, refer to straight-chain or branched alkyl groups having 1 to 4 and 1 to 6 carbon atoms, respectively, bonded through a —S(═O) 2 — moiety, at any position in the alkyl group, e.g. methylsulfonyl. Accordingly, the terms “C 1 -C 4 -haloalkylsulfonyl” and “C 1 -C 6 -haloalkylsulfonyl”, respectively, refer to straight-chain or branched haloalkyl groups having 1 to 4 and 1 to 6 carbon atoms, respectively, bonded through a —S(═O) 2 — moiety, at any position in the haloalkyl group. 
     The term “C 1 -C 4 -alkylamino” refers to an amino radical carrying one C 1 -C 4 -alkyl group as substituent, e.g. methylamino, ethylamino, propylamino, 1-methylethylamino, butylamino, 1-methylpropylamino, 2-methylpropylamino, 1,1-dimethylethylamino and the like. Likewise, the term “C 1 -C 6 -alkylamino” refers to an amino radical carrying one C 1 -C 6 -alkyl group as substituent. 
     The term “di(C 1 -C 4 -alkyl)amino” refers to an amino radical carrying two identical or different C 1 -C 4 -alkyl groups as substituents, e.g. dimethylamino, diethylamino, di-n-propylamino, diisopropylamino, N-ethyl-N-methylamino, N-(n-propyl)-N-methylamino, N-(isopropyl)-N methylamino, N-(n-butyl)-N-methylamino, N-(n-pentyl)-N-methylamino, N-(2-butyl)-N methylamino, N-(isobutyl)-N-methylamino, and the like. Likewise, the term “di(C 1 -C 6 -alkyl)amino” refers to an amino radical carrying two identical or different C 1 -C 6 -alkyl groups as substituents. 
     Accordingly, the terms “C 1 -C 6 -haloalkylamino” and “di(C 1 -C 4 -haloalkyl)amino”, respectively, refer to amino radicals carrying one and two identical or different C 1 -C 6 -alkyl groups as substituents, respectively. 
     The term “C 1 -C 4 -alkylcarbonyl” refers to a C 1 -C 6 -alkyl radical which is attached via a carbonyl group. The term “(C 1 -C 6 -alkoxy)carbonyl” refers to a C 1 -C 6 -alkoxy radical which is attached via a carbonyl group. Accordingly, the terms “C 1 -C 6 -haloalkylcarbonyl” and “C 1 -C 6 -haloalkoxycarbonyl”, respectively, refer to a C 1 -C 6 -alkyl radical and a C 1 -C 6 -alkoxy radical, respectively, which are attached via a carbonyl group. 
     The term “C 1 -C 6 -alkylaminocarbonyl” refers to a C 1 -C 6 -alkylamino radical which is attached via a carbonyl group. Likewise, the term “di(C 1 -C 6 -alkyl)aminocarbonyl” refers to a di(C 1 -C 6 )alkylamino radical which is attached via a carbonyl group. 
     The term “phenoxy” and refers to a phenyl radical which is attached via an oxygen atom. Likewise, the term “phenoxy-C 1 -C 6 -alkyl” and refers to a phenoxy radical which is attached via a C 1 -C 6 -alkyl group. 
     The term “C 2 -C 4 -alkenyl” refers to a straight-chain or branched unsaturated hydrocarbon radical having 2 to 4 carbon atoms and a double bond in any position, e.g. ethenyl, 1-propenyl, 2-propenyl (allyl), 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl. Likewise, the term “C 2 -C 6 -alkenyl” refers to a straight-chain or branched unsaturated hydrocarbon radical having 2 to 6 carbon atoms and a double bond in any position. 
     The term “C 2 -C 4 -alkynyl” refers to a straight-chain or branched unsaturated hydrocarbon radical having 2 to 4 carbon atoms and containing at least one triple bond, such as ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl. Likewise, the term “C 2 -C 6 -alkynyl” refers to a straight-chain or branched unsaturated hydrocarbon radical having 2 to 6 carbon atoms and at least one triple bond. 
     The term “C 3 -C 8 -cycloalkyl” refers to monocyclic, bicyclic and bridged saturated hydrocarbon radicals having 3 to 8 carbon ring members, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl or norbornyl. 
     The term “C 1 -C 6 -alkyl-C 3 -C 8 -cycloalkyl” refers to a cycloalkyl radical having 3 to 8 carbon atoms (as defined above), wherein one hydrogen atom of the cycloalkyl radical is replaced by a C 1 -C 6 -alkyl group. 
     The term “5-, 6- or 7-membered carbocycle” is to be understood as meaning both saturated or partially unsaturated carbocycles having 5, 6 or 7 ring members as well as phenyl. Examples for non-aromatic rings include cyclopentyl, cyclopentenyl, cyclopentadienyl, cyclohexyl, cyclohexenyl, cyclohexadienyl, cycloheptyl, cycloheptenyl, cycloheptadienyl, and the like. 
     The term “5-, 6-, or 7-membered heterocycle” wherein the ring member atoms of the heterocycle include besides carbon atoms one, two, three or four heteroatoms selected from the group of N, O and S, is to be understood as meaning both saturated and partially unsaturated as well as aromatic heterocycles having 5, 6 or 7 ring atoms. Examples include:
         saturated and partially unsaturated 5-, 6-, or 7-membered heterocycle wherein the ring member atoms of the heterocycle include besides carbon atoms 1, 2 or 3 heteroatoms selected from the group of N, O and S, and which is saturated or partially unsaturated, e.g. pyrrolidin-2-yl, pyrrolidin-3-yl, tetrahydrofuran-2-yl, tetrahydrofuran-3-yl, tetrahydrothien-2-yl, tetrahydrothien-3-yl, 1,3-dioxolan-4-yl, isoxazolidin-3-yl, isoxazolidin-4-yl, isoxazolidin-5-yl, isothiazolidin-3-yl, isothiazolidin-4-yl, isothiazolidin-5-yl, pyrazolidin-3-yl, pyrazolidin-4-yl, pyrazolidin-5-yl, oxazolidin-2-yl, oxazolidin-4-yl, oxazolidin-5-yl, thiazolidin-2-yl, thiazolidin-4-yl, thiazolidin-5-yl, imidazolidin-2-yl, imidazolidin-4-yl, 2-pyrrolin-2-yl, 2-pyrrolin-3-yl, 3-pyrrolin-2-yl, 3-pyrrolin-3-yl, piperidin-2-yl, piperidin-3-yl, piperidin-4-yl, 1,3-dioxan-5-yl, tetrahydropyran-2-yl, tetrahydropyran-4-yl, tetrahydrothien-2-yl, hexahydropyridazin-3-yl, hexahydropyridazin-4-yl, hexahydropyrimidin-2-yl, hexahydropyrimidin-4-yl, 5-hexahydropyrimidinyl and piperazin-2-yl;   5-membered heteroaryl (heteroaromatic radical), wherein the ring member atoms of the heteroaryl include besides carbon atoms 1, 2 or 3 heteroatoms selected from the group of N, O and S, e.g. pyrrol-1-yl, pyrrol-2-yl, pyrrol-3-yl, thien-2-yl, thien-3-yl, furan-2-yl, furan-3-yl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl, imidazol-1-yl, imidazol-2-yl, imidazol-4-yl, imidazol-5-yl, oxazol-2-yl, oxazol-4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, thiazol-2-yl, thiazol-4-yl, thiazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl, 1,2,4-triazolyl-1-yl, 1,2,4-triazol-3-yl 1,2,4-triazol-5-yl, 1,2,4-oxadiazol-3-yl, 1,2,4-oxadiazol-5-yl, 1,2,4-thiadiazol-3-yl and 1,2,4-thiadiazol-5-yl;   6-membered heteroaryl (heteroaromatic radical), wherein the ring member atoms of the heteroaryl include besides carbon atoms 1, 2 or 3 heteroatoms selected from the group of N, O and S, e.g. pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, pyridazin-3-yl, pyridazin-4-yl, pyrimidin-2-yl, pyrimidin-4-yl, pyrimidin-5-yl, pyrazin-2-yl and 1,3,5-triazin-2-yl.       

     The term “5- or 6-membered heteroarenediyl” refers to a divalent radical derived from an aromatic heteroaryl having two points of attachment. Examples of heteroarenediyl radicals are, e.g. divalent radicals derived from pyridine, pyrimidine, pyridazine, 1,2,3-triazine, 1,2,4-triazine, 1,2,3,4-tetrazine, furan, thiophene, pyrrole, thiazole, thiadiazole, pyrazole, imidazole, triazole, tetrazole, oxazole, isoxazole, isothiazole, oxadiazole and the like. The aforementioned groups can be C-attached or N-attached where such is possible; e.g. a group derived from pyrrole, imidiazole or pyrazole can be N-attached or C-attached. 
     The term “phenylene” refers to 1,2-phenylene (o-phenylene), 1,3-phenylene (m-phenylene) and 1,4-phenylene (p-phenylene). 
     The term “two radicals R b  that are bound to adjacent ring member atoms of the group A may form together with said ring member atoms a fused 5-, 6- or 7-membered saturated, partially unsaturated or aromatic cycle” refers to a condensed bicyclic ring system, wherein the 5- or 6-membered heteroarenediyl and phenylene, respectively carry a fused-on 5-, 6- or 7-membered carbocyclic or heterocyclic ring. 
     The term “two radicals R c  that are bound to adjacent ring member atoms of the phenyl ring may form together with said ring member atoms a fused 5-, 6- or 7-membered saturated, partially unsaturated or aromatic aromatic cycle, which may be a carbocycle or heterocycle” refers to a condensed bicyclic ring system, wherein the phenyl ring carries a fused-on 5-, 6- or 7-membered carbocyclic or heterocyclic ring. 
     The term “fused-on 5- or 6-membered partially unsaturated or aromatic heterocycle” refers to a 5- or 6-membered partially unsaturated or aromatic heterocycle that is part of a condensed bicyclic ring system. In the case of the group Het, the pyridyl ring carries a fused-on 5- or 6-membered partially unsaturated or aromatic heterocyclic ring bound to the adjacent ring member atoms in position 2 and 3. Accordingly, the term “condensed ring” refers to the overall condensed bicyclic ring system comprising the pyridyl ring and the fused-on 5- or 6-membered partially unsaturated or aromatic heterocycle. 
     The term “condensed ring system comprising Het, R a1  and R a2  and A” refers to 
     
       
         
         
             
             
         
       
     
     wherein R a1  and R a2  are each independently hydrogen or have one of the definitions specified for R a  and wherein * indicates the point of attachment to the methylene bridge bound to the nitrogen atom of the sulfonamide group in the formula I. 
     Agriculturally acceptable salts of compounds I encompass especially the salts of those cations or the acid addition salts of those acids whose cations and anions, respectively, have no adverse effect on the fungicidal action of the compounds I. Suitable cations are thus in particular the ions of the alkali metals, preferably sodium and potassium, of the alkaline earth metals, preferably calcium, magnesium and barium, of the transition metals, preferably manganese, copper, zinc and iron, and also the ammonium ion which, if desired, may carry one to four C 1 -C 4 -alkyl substituents and/or one phenyl or benzyl substituent, preferably diisopropylammonium, tetramethylammonium, tetrabutylammonium, trimethylbenzylammonium, furthermore phosphonium ions, sulfonium ions, preferably tri(C 1 -C 4 -alkyl)sulfonium, and sulfoxonium ions, preferably tri(C 1 -C 4 -alkyl)sulfoxonium. Anions of useful acid addition salts are primarily chloride, bromide, fluoride, hydrogensulfate, sulfate, dihydrogenphosphate, hydrogenphosphate, phosphate, nitrate, bicarbonate, carbonate, hexafluorosilicate, hexafluorophosphate, benzoate, and the anions of C 1 -C 4 -alkanoic acids, preferably formate, acetate, propionate and butyrate. They can be formed by reacting a compound of formula I with an acid of the corresponding anion, preferably of hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid or nitric acid. 
     The compounds of formula I can be present in atropisomers arising from restricted rotation about a single bond of asymmetric groups. They also form part of the subject matter of the present invention. 
     Depending on the substitution pattern, the compounds of formula I and their N-oxides may have one or more centers of chirality, in which case they are present as pure enantiomers or pure diastereomers or as enantiomer or diastereomer mixtures. Both, the pure enantiomers or diastereomers and their mixtures are subject matter of the present invention. 
     In respect of the variables, the embodiments of the intermediates correspond to the embodiments of the compounds I. 
     Preference is given to those compounds I and where applicable also to compounds of all sub-formulae provided herein, e.g. formulae I.1, I.2 and I.3 and to the intermediates such as compounds II, III, IV and IX.a to IX.h, wherein the substituents and variables (Het, m, n, p, R, R 1 , R 2 , A, Y, R a , R b , R c , R d , R e , R f , R n , R′, R″ and R′″) have independently of each other or more preferably in combination the following meanings: 
     One embodiment of the invention relates to compounds I, wherein n is 1 or 2. Another embodiment relates to compounds I, wherein n is 2. A further embodiment relates to compounds I, wherein n is 1. A further embodiment relates to compounds I, wherein n is 0. 
     In one embodiment, R a  is halogen, CN, NH 2 , C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy, C 1 -C 6 -alkylthio, C 1 -C 6 -haloalkylthio, C 1 -C 6 -alkylamino, C 1 -C 6 -haloalkylamino, di(C 1 -C 6 -alkyl)amino, di(C 1 -C 6 -haloalkyl)amino, C 1 -C 6 -alkylcarbonyl, C 1 -C 6 -haloalkylcarbonyl, C 1 -C 6 -alkoxycarbonyl, C 1 -C 6 -haloalkoxycarbonyl, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 1 -C 6 -alkylaminocarbonyl, di(C 1 -C 6 -alkyl)aminocarbonyl. 
     In another embodiment, R a  is halogen, CN, C 1 -C 4 -haloalkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -haloalkoxy, C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl, C 3 -C 8 -cycloalkyl or C 1 -C 4 -alkyl-C 3 -C 8 -cycloalkyl. 
     In a further embodiment, R a  is halogen, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -haloalkoxy, C 1 -C 4 -alkylthio or di(C 1 -C 4 -alkyl)amino. 
     In a further embodiment, R a  is selected from F, Cl, Br, OH, SH, CN, C 1 -C 2 -alkyl, cyclopropyl, CH═CH 2 , C≡CH, C 1 -C 2 -alkoxy, methylthio, methylamino, dimethylamino, CF 3 , CHF 2 , OCF 3  and OCHF 2 , more preferably selected from F, Cl, Br, CN, C 1 -C 2 -alkyl, C 1 -C 2 -alkoxy, CF 3 , CHF2, OCF 3  and OCHF 2 , and particularly preferred selected from Cl, CH 3 , and OCH 3 . 
     In a further embodiment, R a  is Cl, CN, CH 3 , CF 3 , OCH 3 , OCF 3 , N(CH 3 ) 2 , C 1 -C 6 -alkylcarbonyl and preferably selected from C(═O)CH 3 , C(═O)CH(CH 3 ) 2  and C(═O)C(CH 3 ) 3 , C 1 -haloalkylcarbonyl, in particular C(═O)CF 3 , C 1 -C 4 -alkoxycarbonyl and preferably selected from C(═O)OCH 3 , C(═O)OCH(CH 3 ) 2  and C(═O)OC(CH 3 ) 3 , C 1 -haloalkoxycarbonyl, in particular C(═O)OCF 3 , C 1 -C 6 -alkylaminocarbonyl and preferably selected from C(═O)NHCH 3 , C(═O)NHCH(CH 3 ) 2  and C(═O)NHC(CH 3 ) 3 , di(C 1 -C 6 -alkyl)aminocarbonyl and preferably selected from C(═O)N(CH 3 ) 2 , C(═O)N[CH(CH 3 ) 2 ] 2  and C(═O)N[C(CH 3 ) 3 ] 2 . 
     In a further embodiment, R a  is CH 2 CH 3 , CH 2 (CH 3 ) 2 , CF 3 , OCH 3 , OCH 2 CH 3 , isopropoxy, OCF 3 , OCHF 2 , NHCH 3 , N(CH 3 ) 2 , NHCH 2 CH 3  or NHCH 2 (CH 3 ) 2 . 
     In a further embodiment, R a  is CH 2 CH 3 , CH 2 (CH 3 ) 2 , CF 3 , OCH 2 CH 3 , isopropoxy, OCF 3 , OCHF 2 , N(CH 3 ) 2 , NHCH 2 CH 3  or NHCH 2 (CH 3 ) 2 . 
     In a further embodiment, R a  is halogen and preferably selected from F and Cl and in particular, R a  is Cl. In a further embodiment, R a  is CN. In a further embodiment, R a  is C 1 -C 6 -alkyl and preferably selected from methyl, ethyl, n-propyl, i-propyl and t-butyl. In a further embodiment, R a  is C 1 -C 6 -haloalkyl. More preferably, R a  is C 1 -haloalkyl and selected from fluormethyl, difluormethyl, trifluormethyl, chlormethyl, dichlormethyl and trichlormethyl, and in particular, R a  is trifluormethyl. In a further embodiment, R a  is C 1 -C 4 -alkoxy and preferably selected from methoxy, ethoxy, n-propyloxy and i-propyloxy. 
     One embodiment relates to compounds I, wherein the Het is a 5-membered partially unsaturated or aromatic heterocycle, more preferably a partially unsaturated heterocycle. 
     A further embodiment relates to compounds I, wherein Het is a 5- or 6-membered partially unsaturated heterocycle, more preferably a 6-membered partially unsaturated heterocycle. 
     A further embodiment relates to compounds I, wherein Het is a 5- or 6-membered heteroaryl, more preferably a 5-membered heteroaryl. 
     A further embodiment relates to compounds I, wherein Het is a 5-membered heterocycle, preferably selected from the group consisting of dihydrofuran, furan, pyrrole, thiophene, pyrazole, isoxazole, isothiazole, imidazole, oxazole and thiazole. 
     A further embodiment relates to compounds I, wherein Het is a 6-membered heterocycle, and preferably selected from the group consisting of pyrane, pyridine, pyrimidine, pyrazine and pyridazine. 
     A further embodiment relates to compounds I, wherein the Het is selected from the respective column of table P. 
     The groups mentioned in the Table P below are furthermore, independently of the combination in which they are mentioned, a particularly preferred embodiment for Het. 
     Specific embodiments relate to compounds I, wherein R a1  and R a2  are each independently hydrogen or have one of the definitions specified for R a  and wherein the pyridyl group carries one of the following combinations of the fused-on ring, R a1  and R a2  as defined in Table P, which compounds are of formula I.1 
     
       
         
         
             
             
         
       
     
     
       
         
           
               
               
               
               
             
               
                 TABLE P 
               
               
                   
               
               
                 line 
                 R a1   
                 R a2   
                 
                   
                     
                     
                         
                         
                     
                   
                 
               
               
                   
               
             
            
               
                 P-1 
                 H 
                 H 
                 [1,5]naphthyridin-4-yl 
               
               
                 P-2 
                 H 
                 H 
                 [1,6]naphthyridin-4-yl 
               
               
                 P-3 
                 H 
                 H 
                 [1,7]naphthyridin-4-yl 
               
               
                 P-4 
                 H 
                 CF 3   
                 [1,8]naphthyridin-4-yl 
               
               
                 P-5 
                 H 
                 H 
                 pyrido[2,3-d]pyrimidin-5-yl 
               
               
                 P-6 
                 H 
                 Cl 
                 pyrido[2,3-b]pyrazin-8-yl 
               
               
                 P-7 
                 H 
                 H 
                 3,4-dihydro-2H-pyrano[3,2-b]pyridin-8-yl 
               
               
                 P-8 
                 CN 
                 H 
                 3,4-dihydro-2H-pyrano[2,3-b]pyridin-5-yl 
               
               
                 P-9 
                 H 
                 H 
                 3,4-dihydro-2H-pyrano[2,3-b]pyridin-5-yl 
               
               
                 P-10 
                 H 
                 H 
                 1-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl 
               
               
                 P-11 
                 H 
                 H 
                 1-methyl-1H-pyrrolo[3,2-b]pyridin-7-yl 
               
               
                 P-12 
                 CH 3   
                 CH 3   
                 thieno[2,3-b]pyridin-4-yl 
               
               
                 P-13 
                 H 
                 H 
                 thieno[3,2-b]pyridin-7-yl 
               
               
                 P-14 
                 H 
                 OCF 3   
                 thiazolo[4,5-b]pyridin-7-yl 
               
               
                 P-15 
                 H 
                 H 
                 2-methyl-thiazolo[4,5-b]pyridin-7-yl 
               
               
                 P-16 
                 H 
                 H 
                 thiazolo[5,4-b]pyridin-7-yl 
               
               
                 P-17 
                 H 
                 H 
                 2-methyl-thiazolo[5,4-b]pyridin-7-yl 
               
               
                 P-18 
                 H 
                 H 
                 1-ethyl-1H-imidazo[4,5-b]pyridin-7-yl 
               
               
                 P-19 
                 H 
                 H 
                 1,2-dimethyl-1H-imidazo[4,5-b]pridin-7-yl 
               
               
                 P-20 
                 H 
                 H 
                 3-methyl-3H-imidazo[4,5-b]pyridin-7-yl 
               
               
                 P-21 
                 H 
                 OCH 3   
                 oxazolo[4,5-b]pyridin-7-yl 
               
               
                 P-22 
                 H 
                 H 
                 oxazolo[5,4-b]pyridin-7-yl 
               
               
                 P-23 
                 H 
                 H 
                 2,3-dimethyl-3H-imidazo[4,5-b]pyridin-7-yl 
               
               
                 P-24 
                 H 
                 H 
                 2-methyl-oxazolo[4,5-b]pyridin-7-yl 
               
               
                 P-25 
                 H 
                 H 
                 2-methyl-oxazolo[5,4-b]pyridin-7-yl 
               
               
                 P-26 
                 H 
                 N(CH 3 ) 2   
                 2,3-dihydro-furo[2,3-b]pyridin-4-yl 
               
               
                 P-27 
                 H 
                 H 
                 2,3-dihydro-furo[2,3-b]pyridin-4-yl 
               
               
                 P-28 
                 OCHF 2   
                 H 
                 2,3-dihydro-furo[3,2-b]pyridin-7-yl 
               
               
                 P-29 
                 H 
                 H 
                 2,3-dihydro-furo[3,2-b]pyridin-7-yl 
               
               
                 P-30 
                 H 
                 H 
                 2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-8-yl 
               
               
                 P-31 
                 H 
                 H 
                 2,2-dimethyl-[1,3]dioxolo[4,5-b]pyridin-7-yl 
               
               
                 P-32 
                 H 
                 H 
                 2-methyl-[1,3]dioxolo[4,5-b]pyridin-7-yl 
               
               
                 P-33 
                 H 
                 H 
                 [1,3]dioxolo[4,5-b]pyridin-7-yl 
               
               
                 P-34 
                 H 
                 H 
                 2,2-dimethoxy-[1,3]dioxolo[4,5-b]pyridin-7-yl, 
               
               
                   
               
               
                 wherein * indicates the point of attachment to the methylene bridge bound to the nitrogen atom of the sulfonamide group. 
               
            
           
         
       
     
     One embodiment relates to compounds I, wherein R is hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkylcarbonyl or C 1 -C 6 -haloalkylcarbonyl, preferably hydrogen or C 1 -C 6 -alkyl. 
     Another embodiment relates to compounds I, wherein R is hydrogen, C 1 -C 4 -alkyl, C 1 -C 2 -haloalkoxy, di(C 1 -C 2 -alkyl)amino, allyl or propargyl. 
     A further embodiment relates to compounds I, wherein R is hydrogen, C 1 -C 4 -alkyl, —CH═CH 2 , —CH 2 —CH═CH 2  or —CH 2 —C≡CH. 
     A further embodiment relates to compounds I, wherein R is C 1 -C 4 -alkyl and preferably selected from methyl, ethyl, n-propyl and i-propyl, and in particular, R is methyl. 
     A further embodiment relates to compounds I, wherein R is hydrogen and wherein R a1 , R a2  and R a1  are each independently hydrogen or have one of the definitions specified for R a , especially those being preferred, which compounds are of formula I.2 
     
       
         
         
             
             
         
       
     
     One embodiment relates to compounds I, wherein A is phenylene, which ist unsubstituted or carries one, two, three or four identical or different substituents R b , with 1,3-phenylene or 1,4-phenylene being preferred. 
     Another embodiment relates to compounds I, wherein A is 1,4-phenylene, which is unsubstituted or carries 1, 2, 3 or 4 identical or different substituents R b , in particular A is 1,4-phenylene, which is unsubstituted. 
     A further embodiment relates to compounds I, wherein A is phenylene or a 5- or 6-membered heteroarenediyl, wherein the ring member atoms of the heteroarenediyl include besides carbon atoms 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein the aforementioned divalent radicals are unsubstituted or carry 1, 2, 3 or 4 identical or different groups R b . 
     A further embodiment relates to compounds I, wherein A is a heteroarenediyl selected from the group consisting of pyrimidindiyl, pyridazindiyl, pyrazindiyl, triazindiyl, furandiyl, pyrroldiyl, pyrazoldiyl, isoxazoldiyl, isothiazoldiyl, imidazoldiyl, oxazoldiyl, thiazoldiyl, triazoldiyl, thiadiazoldiyl and oxadiazoldiyl, and wherein the aforementioned radicals are unsubstituted or carry 1, 2 or 3 identical or different substituents R b . If one point of attachment is located on a nitrogen atom of the heteroarenediyl radical, said nitrogen atom is attached either to the sulfur atom of the sulfonamide group or to Y, with the point of attachment to Y being more preferred. In the another embodiment, A is pyrimidindiyl. In a further embodiment, A is pyridazindiyl. In a further embodiment, A is pyrazindiyl. In a further embodiment, A is furandiyl. In a further embodiment, A is pyrroldiyl. In a further embodiment, A is pyrazoldiyl. In a further embodiment, A is isoxazoldiyl. In a further embodiment, A is isothiazoldiyl. In a further embodiment, A is imidazoldiyl. In a further embodiment, A is oxazoldiyl. In a further embodiment, A is thiazoldiyl. In a further embodiment, A is 1,2,4-triazoldiyl. In a further embodiment, A is 1,2,4-thiadiazoldiyl. In a further embodiment, A is 1,2,4-oxadiazoldiyl. 
     A further embodiment relates to compounds I, wherein A is a 6-membered heteroarenediyl, which is unsubstituted or carries 1, 2, 3 or 4 identical or different substituents R b . 
     A further embodiment relates to compounds I, wherein A is a heteroarenediyl selected from the group consisting of pyrimidindiyl, pyridazindiyl, pyrazindiyl, furandiyl, thiendiyl and pyrazoldiyl, and more preferably selected from the group consisting of pyrimidindiyl, pyridazindiyl and pyrazindiyl, and wherein the aforementioned radicals are unsubstituted or carry 1, 2, 3 or 4 identical or different substituents R b . A further embodiment relates to compounds I, wherein A is thiendiyl. 
     Amongst compounds I, wherein A is a 6-membered heteroarenediyl, particular preference given to those, wherein A is pyrimidinyl, wherein each of the aforementioned two radicals are unsubstituted or carry 1, 2 or 3 identical or different substituents R b , and most preference is given to those, wherein A is selected from the group consisting of pyrimidin-2,5-diyl, pyrimidin-2,4-diyl and pyrimidin-4,6-diyl wherein the aforementioned heteroarenediyl radicals are unsubstituted or carry 1, 2, 3 or 4 identical or different substituents R b . 
     A further embodiment relates to compounds I, wherein A is a 5-membered heteroarenediyl, which is unsubstituted or carries 1, 2, 3 or 4 identical or different substituents R b . 
     Amongst compounds I, wherein A is a 5-membered heteroarenediyl, particular preference given to those, wherein A is thiazoldiyl, oxazoldiyl or pyrazoldiyl, wherein each of the aforementioned five radicals are unsubstituted or carry 1, 2 or 3 identical or different substituents R b . 
     Particularly preferred embodiments of the invention relate to compounds I, in which A is one of the following radicals A-1 to A-5: 
     
       
         
           
               
               
             
               
                   
               
               
                 No. 
                 A 
               
               
                   
               
             
            
               
                 A-1 
                 
                   
                     
                     
                         
                         
                     
                   
                 
               
               
                   
               
               
                 A-2 
                 
                   
                     
                     
                         
                         
                     
                   
                 
               
               
                   
               
               
                 A-3 
                 
                   
                     
                     
                         
                         
                     
                   
                 
               
               
                   
               
               
                 A-4 
                 
                   
                     
                     
                         
                         
                     
                   
                 
               
               
                   
               
               
                 A-5 
                 
                   
                     
                     
                         
                         
                     
                   
                 
               
               
                   
               
               
                 wherein # indicates the bond to the sulfur atom of the sulfonamide group; and * indicates the bond to Y. 
               
            
           
         
       
     
     One embodiment of the invention relates to compounds I, wherein the group A carries 1, 2 or 3 radicals R b , more preferably 1 or 2 radicals R b . In another embodiment, the group A is unsubstituted or carries 1 radical R b . In a further embodiment, the group A is unsubstituted. In a further embodiment, the group A carries 1 radical R b . In a further embodiment, the group A carries 2 radicals R b . In a further embodiment, the group A carries 3 radicals R b . 
     If R b  is present, R b  is preferably halogen, CN, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -haloalkoxy, C 2 -C 4 -alkenyl, C 2 -C 4 -haloalkenyl, C 2 -C 4 -alkynyl, C 2 -C 4 -haloalkynyl, C 1 -C 4 -alkylcarbonyl, C 1 -C 4 -alkoxycarbonyl, di(C 1 -C 4 -alkyl)amino, C 1 -C 4 -alkylaminocarbonyl or di(C 1 -C 4 -alkyl)aminocarbonyl. More preferably, R b  is halogen, CN, C 1 -C 4 -haloalkyl, C 1 -C 4 -alkoxy or C 1 -C 4 -haloalkoxy. Another embodiment relates to compounds I, wherein R b  is halogen, CN, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl or C 1 -C 4 -alkoxy. A further embodiment relates to compounds I, wherein R b  is halogen, CN, C 1 -C 2 -alkyl, C 1 -C 2 -haloalkyl or C 1 -C 2 -alkoxy. A further embodiment relates to compounds I, wherein R b  is F, Cl, CN, C 1 -C 2 -alkyl, C 1 -C 2 -haloalkyl or C 1 -C 2 -alkoxy. A further embodiment relates to compounds I, wherein R b  is F, Cl, CN, CH 3 , OCH 3 , CF 3  or OCHF 2 . A further embodiment relates to compounds I, wherein R b  is F or CH 3 . 
     In a further embodiment, R b  is halogen and preferably selected from fluorine and chlorine, and in particular, chlorine. In a further embodiment, R b  is CN. In a further embodiment, R b  is C 1 -C 4 -alkyl and preferably selected from methyl, ethyl, n-propyl and i-propyl, and in particular, methyl. In a further embodiment, R b  is C 1 -C 4 -haloalkyl. More preferably, R b  is C 1 -haloalkyl, and in particular, trifluoromethyl. In a further embodiment, R b  is C 1 -C 4 -alkoxy and preferably selected from methoxy and ethoxy. 
     In a further embodiment, two radicals R b  that are bound to adjacent ring member atoms of the group A do not form together with said ring member atoms any fused cycle. 
     A further embodiment relates to compounds I, wherein two radicals R b  that are bound to adjacent ring member atoms of the group A form together with said ring member atoms a fused cycle being a fused 5-, 6- or 7-membered saturated, partially unsaturated or aromatic carbocycle or heterocycle, wherein the ring member atoms of the fused heterocycle include besides carbon atoms 1, 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein the fused cycle is unsubstituted and carries 1, 2, 3 or 4 identical or different groups as defined for R b . In one embodiment, the fused cycle is preferably phenyl. In another embodiment, the fused cycle is preferably a saturated carbocycle and in particular cyclohexyl. In a further embodiment, the fused cycle is preferably a partially unsaturated carbocycle and in particular cyclohexenyl. 
     One embodiment of the invention relates to compounds I, wherein p is 1, 2 or 3, preferably 1 or 2, in particular 1. A further embodiment relates to compounds I, wherein p is 2. A further embodiment relates to compounds I, wherein p is 3. A further embodiment relates to compounds I, wherein p is 0. In a further embodiment, two radicals R c  that are bound to adjacent ring member atoms of the phenyl ring do not form together with said ring member atoms any fused cycle. 
     Preferably, R c  is halogen, CN, C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, C 1 -C 6 -haloalkoxy, C 1 -C 6 -alkoxy-C 1 -C 6 -alkyl, C(═O)R′, C(═NOR″)R′″, C 3 -C 8 -cycloalkyl, C 1 -C 6 -alkyl-C 3 -C 8 -cycloalkyl, phenyl, phenoxy, phenoxy-C 1 -C 4 -alkyl or a 5- or 6-membered heteroaryl, wherein the ring member atoms of the heteroaryl include besides carbon atoms 1, 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein the aforementioned cyclic radicals are unsubstituted or carry 1, 2, 3 or 4 identical or different substituents R d . 
     In one embodiment, is halogen and preferably selected from F and Cl and in particular, R c  is Cl. In another embodiment, R c  is CN. In a further embodiment, R c  is C 1 -C 6 -alkyl and preferably selected from methyl, ethyl, n-propyl and i-propyl, and in particular, R c  is methyl. In a further embodiment, R′ is C 1 -C 6 -haloalkyl. More preferably, R c  is C 1 -haloalkyl and selected from fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl and trichloromethyl, and in particular, R c  is trifluoromethyl. In a further embodiment, R c  is C 1 -C 6 -alkoxy and preferbly selected from methoxy and ethoxy. In a further embodiment, R c  is C 3 -C 8 -cycloalkyl and preferably selected from cyclopropyl, cylopentyl and cyclohexyl, and in particular, R c  is cyclopropyl. In a further embodiment, R e  is C 1 -C 6 -alkyl-C 3 -C 8 -cycloalkyl and selected from cylopropylmethyl, cyclobutylmethyl, cyclopentylmethyl, cyclohexylmethyl, cycloheptylmethyl and cyclooctylmethyl. In a further embodiment, R c  is phenyl. In a further embodiment, R c  is phenoxy. In a further embodiment, R e  is phenoxy-C 1 -C 6 -alkyl and selected from phenoxymethyl, 1-phenoxy-ethyl and 2-phenoxyethyl. 
     In a further embodiment, R c  is a 6-membered heteroaryl, wherein the ring member atoms of the heteroaryl include besides carbon atoms 1, 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein R e  is unsubstituted or carries 1, 2, 3 or 4 identical or different groups R d . 
     If R c  is a 5-membered heteroaryl, R e  carries 1 heteroatom as ring member atom. In another embodiment, R e  is a furanyl radical that is unsubstituted or carries 1, 2 or 3 identical or different substituents R d . In a further embodiment, R e  is a thienyl radical that is unsubstituted or carries 1, 2 or 3 identical or different substituents R d . In a further embodiment, R e  is a pyrrolyl radical selected from pyrrol-2-yl and pyrrol-3-yl, wherein the aforementioned pyrrolyl radicals are unsubstituted or carry 1, 2, 3 or 4 identical or different substituents R d . 
     If R c  is a 5-membered heteroaryl, R c  carries 2 heteroatoms as ring member atoms. In a further embodiment, R c  is a pyrazolyl radical selected from pyrazol-3-yl, pyrazol-4-yl and pyrazol-5-yl, wherein the aforementioned pyrazolyl radicals are unsubstituted or carry 1, 2 or 3 identical or different substituents R d . In a further embodiment, R′ is an isoxazolyl radical that is unsubstituted or carries 1 or 2 identical or different substituents R d . In a further embodiment, R c  is an isothiazolyl radical that is unsubstituted or carries 1 or 2 identical or different substituents R d . In a further embodiment, R c  is an imidazolyl radical that is unsubstituted or carries 1, 2 or 3 identical or different substituents R d . In a further embodiment, R c  is an oxazolyl radical that is unsubstituted or carries 1 or 2 identical or different substituents R d . In a further embodiment, R c  is a thiazolyl radical that is unsubstituted or carries 1 or 2 identical or different substituents R d . 
     A further embodiment relates to compounds I, wherein two radicals R c  that are bound to adjacent ring member atoms of the phenyl ring form together with said ring member atoms a fused cycle being a fused 5-, 6- or 7-membered saturated, partially unsaturated or aromatic carbocycle or heterocycle, wherein the ring member atoms of the fused heterocycle include besides carbon atoms 1, 2, 3 or 4 heteroatoms selected from the group of N, O and S, and wherein the fused cycle is unsubstituted and carries 1, 2, 3 or 4 identical or different R e  radicals. In one embodiment, the fused cycle is preferably phenyl. In another embodiment, the fused cycle is preferably a saturated carbocycle and in particular cyclohexyl. In a further embodiment, the fused cycle is preferably a partially unsaturated carbocycle and in particular cyclohexenyl. 
     If R c  is C(═O)R′, R′ is selected from NH 2 , C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -alkoxy-C 1 -C 4 -alkoxy, C 1 -C 4 -haloalkoxy, C 1 -C 4 -alkylamino and di(C 1 -C 4 -alkyl)amino. If R c  is C(═O)R′, R′ is preferably NH 2 . If R c  is C(═O)R′, R′ is preferably C 1 -C 4 -alkyl and in particular, methyl. If R e  is C(═O)R′, R′ is preferably C 1 -C 4 -alkoxy and more preferably selected from methoxy and ethoxy. If R c  is C(═O)R′, R′ is preferably C 1 -C 4 -haloalkyl. More preferably, R′ is C 1 -haloalkyl and selected from fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl and trichloromethyl. If R e  is C(═O)R′, R′ is preferably C 1 -C 4 -haloalkoxy and preferably halomethoxy, such as difluoromethoxy, trifluoromethoxy, dichloromethoxy and trichloromethoxy, or haloethoxy, such as 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2,2-dichloroethoxy and 2,2,2-trichloroethoxy. If R e  is C(═O)R′, R′ is preferably C 1 -C 4 -alkoxy-C 1 -C 4 -alkoxy and selected from methoxy-methoxy, methoxy-ethoxy, ethoxy-methoxy and ethoxy-ethoxy. If R c  is C(═O)R′, R′ is preferably C 1 -C 4 -alkylamino and in particular selected from methylamino and ethylamino. If R c  is C(═O)R′, R′ is preferably di(C 1 -C 4 -alkyl)amino and more preferably selected from dimethylamino, methyl-ethyl-amino, methyl-n-propyl-amino, methyl-i-propyl-amino, methyl-n-butyl-amino, methyl-(1-methyl-propyl)-amino, methyl(2-methylpropyl)-amino, methyl-(1,1-dimethylethyl)-amino, diethylamino, and in particular from dimethylamino, methyl-ethylamino and diethylamino. 
     If R e  is C(═NOR″)R′″, in one embodiment, R″ is C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 2 -C 4 -alkenyl, C 2 -C 4 -alkynyl or C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl. 
     If R c  is C(═NOR″)R′″, R″ is preferably C 1 -C 4 -alkyl and more preferably selected from methyl, ethyl, n-propyl, i-propyl, and in particular, R″ is methyl. If R c  is C(═NOR″)R′″, R″ is preferably C 2 -C 4 -alkenyl and selected from vinyl, prop-1-en-3-yl, but-1-en-3-yl, but-1-en-4-yl and but-2-en-1-yl. If R e  is C(═NOR″)R′″, R″ is preferably C 2 -C 4 -alkynyl and selected from prop-1-in-3-yl, but-1-in-3-yl, but-1-in-4-yl and but-2-in-1-yl. If R e  is C(═NOR″)R′″, R″ is preferably C 1 -C 4 -alkoxy-C 1 -C 4 -alkyl and more preferably selected from methoxymethyl, ethoxymethyl, methoxyethyl and ethoxyethyl. 
     If R c  is C(═NOR″)R′″, R′″ is C 1 -C 4 -alkyl and preferably selected from methyl, ethyl, n-propyl, i-propyl, and in particular, R′″ is methyl. If R e  is C(═NOR″)R′″, in another embodiment, R′″ is hydrogen. 
     If R e  is present, one embodiment relates to compounds I, wherein R e  carries 1, 2, 3 or 4 radicals R d , preferably 1, 2 or 3 radicals R d , and more preferably 1 or 2 radicals R d . 
     In another embodiment, R e  carries one radical R d . In a further embodiment, R e  carries two radicals R d . In a further embodiment the group R e  carries three radicals R d . 
     In one embodiment, R d  is halogen and preferably selected from F and Cl, and in particular, Cl. In another embodiment, R d  is CN. In a further embodiment, R d  is C 1 -C 4 -alkyl and preferably selected from methyl, ethyl, n-propyl and i-propyl and in particular, R d  is methyl. In a further embodiment, R d  is C 1 -C 4 -haloalkyl. More preferably, R c  is C 1 -haloalkyl and selected from fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl and trichloromethyl, and in particular, R d  is trifluoromethyl. In a further embodiment, R d  is C 1 -C 4 -alkoxy and preferably selected from methoxy and ethoxy. In a further embodiment, R d  is C 1 -C 4 -haloalkoxy and preferably halomethoxy such as difluoromethoxy, trifluoromethoxy, dichloromethoxy and trichloromethoxy; or haloethoxy such as 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2,2-dichloroethoxy and 2,2,2-trichloroethoxy. 
     Particularly preferred embodiments of the invention relate to compounds I, wherein the phenyl group carries one of the following combinations of R c1 , R c2 , R c3 , R c4  and R c5  as defined in Table A: 
     
       
         
           
               
               
               
               
               
               
             
               
                 TABLE A 
               
               
                   
               
               
                 line 
                 R c1   
                 R c2   
                 R c3   
                 R c4   
                 R c5   
               
               
                   
               
             
            
               
                   
               
            
           
           
               
               
               
               
               
               
            
               
                 1 
                 F 
                 H 
                 H 
                 H 
                 H 
               
               
                 2 
                 Cl 
                 H 
                 H 
                 H 
                 H 
               
               
                 3 
                 CF 3   
                 H 
                 H 
                 H 
                 H 
               
               
                 4 
                 H 
                 H 
                 F 
                 H 
                 H 
               
               
                 5 
                 H 
                 H 
                 Cl 
                 H 
                 H 
               
               
                 6 
                 H 
                 H 
                 CF 3   
                 H 
                 H 
               
               
                 7 
                 F 
                 H 
                 F 
                 H 
                 H 
               
               
                 8 
                 Cl 
                 H 
                 F 
                 H 
                 H 
               
               
                 9 
                 F 
                 H 
                 Cl 
                 H 
                 H 
               
               
                 10 
                 F 
                 H 
                 CF 3   
                 H 
                 H 
               
               
                 11 
                 Cl 
                 H 
                 CF 3   
                 H 
                 H 
               
               
                 12 
                 CF 3   
                 H 
                 CF 3   
                 H 
                 H 
               
               
                 13 
                 F 
                 H 
                 H 
                 H 
                 F 
               
               
                 14 
                 Cl 
                 H 
                 H 
                 H 
                 F 
               
               
                 15 
                 Br 
                 H 
                 H 
                 H 
                 F 
               
               
                 16 
                 F 
                 H 
                 H 
                 H 
                 Cl 
               
               
                 17 
                 Cl 
                 H 
                 H 
                 H 
                 Cl 
               
               
                 18 
                 F 
                 H 
                 H 
                 H 
                 CF 3   
               
               
                 19 
                 Cl 
                 H 
                 H 
                 H 
                 CF 3   
               
               
                 20 
                 CF 3   
                   
                 H 
                 H 
                 CF 3   
               
               
                   
               
            
           
         
       
     
     A further embodiment relates to compounds I, wherein R is hydrogen and wherein R a1  and R a2  are each independently hydrogen or have one of the definitions specified for R a , and R c1 , R c2 , R c3 , R c4  and R c5  are each independently hydrogen or have one of the definitions specified for R c , especially those being preferred, which compounds are of formula I.3 
     
       
         
         
             
             
         
       
     
     One embodiment relates to compounds I, wherein Y is a direct bond, —O—, —S— or —NH—. Another embodiment relates to compounds I, wherein Y is —S— or —O—. A further embodiment relates to compounds I, wherein R is hydrogen, and Y is —O—, and R a1  and R a2  are each independently hydrogen or have one of the definitions specified for R a , and R c1 , R c2 , R c3 , R c4  and R c5  are each independently hydrogen or have one of the definitions specified for R c , which are represented by formula I.A: 
     
       
         
         
             
             
         
       
     
     A further embodiment relates to compounds I, wherein R is hydrogen and Y is a direct bond, and R a1  and R a2  are each independently hydrogen or have one of the definitions specified for R a , and R c1 , R c2 , R c3 , R c4  and R c5  are each independently hydrogen or have one of the definitions specified for R c , which are represented by formula I.B: 
     
       
         
         
             
             
         
       
     
     A further embodiment relates to compounds I, wherein Y is —N(R n )—, wherein R n  is hydrogen or C 1 -C 4 -alkyl. If R n  is present, in one embodiment of the invention, R n  is C 1 -C 4 -alkyl, and preferably selected from methyl, ethyl, n-propyl and i-propyl, and in particular, R n  is methyl. Particullarly preferred compounds I, wherein R is hydrogen and Y is —N(CH 3 )—, and R a1  and R a2  are each independently hydrogen or have one of the definitions specified for R a , and R c1 , R c2 , R c3 , R c4  and R c5  are each independently hydrogen or have one of the definitions specified for R c , which are represented by formula I.C: 
     
       
         
         
             
             
         
       
     
     A further embodiment relates to compounds I, wherein R is hydrogen and Y is —NH—, and R a1  and R a2  are each independently hydrogen or have one of the definitions specified for R a , and R c1 , R c2 , R c3 , R c4  and R c5  are each independently hydrogen or have one of the definitions specified for R c , which are represented by formula I.D: 
     
       
         
         
             
             
         
       
     
     A further embodiment relates to compounds I, wherein R is hydrogen and Y is —S—, and R a1  and R a2  are each independently hydrogen or have one of the definitions specified for R a , and R c1 , R c2 , R c3 , R c4  and R c5  are each independently hydrogen or have one of the definitions specified for R c , which are represented by formula I.E: 
     
       
         
         
             
             
         
       
     
     A further embodiment relates to compounds I, wherein R is hydrogen and Y is —S(═O)—, and R a1  and R a2  are each independently hydrogen or have one of the definitions specified for R a , and R c1 , R c2 , R c3 , R c4  and R c5  are each independently hydrogen or have one of the definitions specified for R c , which are represented by formula I.F: 
     
       
         
         
             
             
         
       
     
     A further embodiment relates to compounds I, wherein R is hydrogen and Y is —S(═O) 2 —, and R a1  and R a2  are each independently hydrogen or have one of the definitions specified for R a , and R c1 , R c2 , R c3 , R c4  and R c5  are each independently hydrogen or have one of the definitions specified for R c , which are represented by formula I.G: 
     
       
         
         
             
             
         
       
     
     A further embodiment relates to compounds I, wherein Y is —CH 2 —. A more specific embodiment relates to compounds I, wherein R is hydrogen, Y is —CH 2 —, and R a1  and R a2  are each independently hydrogen or have one of the definitions specified for R a , and R c1 , R c2 , R c3 , R c4  and R c5  are each independently hydrogen or have one of the definitions specified for R c , which compounds are of formula I.H: 
     
       
         
         
             
             
         
       
     
     A further embodiment relates to compounds I, wherein R is hydrogen and Y is —O(CH 2 )—, and R a1  and R a2  are each independently hydrogen or have one of the definitions specified for R a , and R c1 , R c2 , R c3 , R c4  and R c5  are each independently hydrogen or have one of the definitions specified for R c , which are represented by formula I.J: 
     
       
         
         
             
             
         
       
     
     A further embodiment relates to compounds I, wherein R is hydrogen and Y is —(CH 2 )O—, and R a1  and R a2  are each independently hydrogen or have one of the definitions specified for R a , and R c1 , R c2 , R c3 , R c4  and R c5  are each independently hydrogen or have one of the definitions specified for R e , which are represented by formula I.K: 
     
       
         
         
             
             
         
       
     
     A skilled person will readily understand that the preferences given in connection with compounds I apply for formulae I.1, I.2 and I.3 and formulae I.A to I.K as defined above. 
     Here, the groups mentioned in the Tables for a substituent are furthermore, independently of the combination in which they are mentioned, a particularly preferred embodiment of the substituent in question. 
     With respect to their use, particular preference is given to the compounds I compiled in the Tables 1 to 1700 below, wherein the definitions for the Het group and its substituents (R f ) m  and the substituents R a1  and R a2  of the pyridine group are selected from P-1 to P-34 in Table P and wherein the definitions for group A are selected from A-1 to A-5 as described above. Here, the groups mentioned in the Tables for a substituent are furthermore, independently of the combination in which they are mentioned, a particularly preferred embodiment of the substituent in question. 
     Table 1: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-1, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 2: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-2, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 3: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-3, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 4: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-4, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 5: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-5, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 6: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-6, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 7: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-7, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 8: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-8, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 9: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-9, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 10: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-10, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 11: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-11, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 12: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-12, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 13: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-13, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 14: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-14, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 15: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-15, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 16: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-16, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 17: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-17, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 18: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-18, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 19: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-19, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 20: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-20, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 21: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-21, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 22: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-22, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 23: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-23, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 24: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-24, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 25: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-25, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 26: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-26, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 27: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-27, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 28: Compounds of formula I.A, wherein the condensed ring system comprising
 
     Het, R a1  and R a2  is defined as in line P-28, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A. 
     Table 29: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-29, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 30: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-30, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 31: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-31, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 32: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-32, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 33: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-33, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Table 34: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in line P-34, A is A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Tables 35 to 68: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in Tables 1 to 34 and A is A-2 instead of A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Tables 69 to 102: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in Tables 1 to 34 and A is A-3 instead of A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Tables 103 to 136: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in Tables 1 to 34 and A is A-4 instead of A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Tables 137 to 170: Compounds of formula I.A, wherein the condensed ring system comprising Het, R a1  and R a2  is defined as in Tables 1 to 34 and A is A-5 instead of A-1 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Tables 171 to 340: Compounds of formula I.B, wherein the condensed ring system comprising Het, R a1  and R a2  and A are defined as in Tables 1 to 170 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Tables 341 to 510: Compounds of formula I.C, wherein the condensed ring system comprising Het, R a1  and R a2  and A are defined as in Tables 1 to 170 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Tables 511 to 680: Compounds of formula I.D, wherein the condensed ring system comprising Het, R a1  and R a2  and A are defined as in Tables 1 to 170 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Tables 681 to 850: Compounds of formula I.E, wherein the condensed ring system comprising Het, R a1  and R a2  and A are defined as in Tables 1 to 170 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Tables 851 to 1020: Compounds of formula I.F, wherein the condensed ring system comprising Het, R a1  and R a2  and A are defined as in Tables 1 to 170 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Tables 1021 to 1190: Compounds of formula I.G, wherein the condensed ring system comprising Het, R a1  and R a2  and A are defined as in Tables 1 to 170 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Tables 1191 to 1360: Compounds of formula I.H, wherein the condensed ring system comprising Het, R a1  and R a2  and A are defined as in Tables 1 to 170 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Tables 1361 to 1530: Compounds of formula I.J, wherein the condensed ring system comprising Het, R a1  and R a2  and A are defined as in Tables 1 to 170 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
Tables 1531 to 1700: Compounds of formula I.K, wherein the condensed ring system comprising Het, R a1  and R a2  and A are defined as in Tables 1 to 170 and the meaning of R c1 , R c2 , R c3 , R c4  and R c5  for each compound corresponds to one line of table A.
 
     The compounds I and the compositions according to the invention, respectively, are suitable as fungicides. They are distinguished by an outstanding effectiveness against a broad spectrum of phytopathogenic fungi, including soil-borne fungi, which derive especially from the classes of the Plasmodiophoromycetes, Peronosporomycetes (syn. Oomycetes), Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deuteromycetes (syn. Fungi imperfecti). Some are systemically effective and they can be used in crop protection as foliar fungicides, fungicides for seed dressing and soil fungicides. Moreover, they are suitable for controlling harmful fungi, which inter alia occur in wood or roots of plants. 
     The compounds I and the compositions according to the invention are particularly important in the control of a multitude of phytopathogenic fungi on various cultivated plants, such as cereals, e.g. wheat, rye, barley, triticale, oats or rice; beet, e.g. sugar beet or fodder beet; fruits, such as pomes, stone fruits or soft fruits, e.g. apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries, blackberries or gooseberries; leguminous plants, such as lentils, peas, alfalfa or soybeans; oil plants, such as rape, mustard, olives, sunflowers, coconut, cocoa beans, castor oil plants, oil palms, ground nuts or soybeans; cucurbits, such as squashes, cucumber or melons; fiber plants, such as cotton, flax, hemp or jute; citrus fruit, such as oranges, lemons, grapefruits or mandarins; vegetables, such as spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes, cucurbits or paprika; lauraceous plants, such as avocados, cinnamon or camphor; energy and raw material plants, such as corn, soybean, rape, sugar cane or oil palm; corn; tobacco; nuts; coffee; tea; bananas; vines (table grapes and grape juice grape vines); hop; turf; natural rubber plants or ornamental and forestry plants, such as flowers, shrubs, broad-leaved trees or evergreens, e.g. conifers; and on the plant propagation material, such as seeds, and the crop material of these plants. 
     Preferably, compounds I and compositions thereof, respectively are used for controlling a multitude of fungi on field crops, such as potatoes sugar beets, tobacco, wheat, rye, barley, oats, rice, corn, cotton, soybeans, rape, legumes, sunflowers, coffee or sugar cane; fruits; vines; ornamentals; or vegetables, such as cucumbers, tomatoes, beans or squashes. 
     The term “plant propagation material” is to be understood to denote all the generative parts of the plant such as seeds and vegetative plant material such as cuttings and tubers (e.g. potatoes), which can be used for the multiplication of the plant. This includes seeds, roots, fruits, tubers, bulbs, rhizomes, shoots, sprouts and other parts of plants, including seedlings and young plants, which are to be transplanted after germination or after emergence from soil. These young plants may also be protected before transplantation by a total or partial treatment by immersion or pouring. 
     Preferably, treatment of plant propagation materials with compounds I and compositions thereof, respectively, is used for controlling a multitude of fungi on cereals, such as wheat, rye, barley and oats; rice, corn, cotton and soybeans. 
     The term “cultivated plants” is to be understood as including plants which have been modified by breeding, mutagenesis or genetic engineering including but not limiting to agricultural biotech products on the market or in development (cf. http://www.bio.org/speeches/pubs/er/agri_products.asp). Genetically modified plants are plants, which genetic material has been so modified by the use of recombinant DNA techniques that under natural circumstances cannot readily be obtained by cross breeding, mutations or natural recombination. Typically, one or more genes have been integrated into the genetic material of a genetically modified plant in order to improve certain properties of the plant. Such genetic modifications also include but are not limited to targeted post-translational modification of protein(s), oligo- or polypeptides e.g. by glycosylation or polymer additions such as prenylated, acetylated or farnesylated moieties or PEG moieties. 
     The compounds I and compositions thereof, respectively, are particularly suitable for controlling the following plant diseases: 
       Alternaria  spp. ( Alternaria  leaf spot) on vegetables, rape ( A. brassicola  or  brassicae ), sugar beets ( A. tenuis ), fruits, rice, soybeans, potatoes (e.g.  A. solani  or  A. alternata ), tomatoes (e.g.  A. solani  or  A. alternata ) and wheat;  Bipolaris  and  Drechslera  spp. (teleomorph:  Cochliobolus  spp.), e.g. Southern leaf blight ( D. maydis ) or Northern leaf blight ( B. zeicola ) on corn, e.g. spot blotch ( B. sorokiniana ) on cereals and e.g.  B. oryzae  on rice and turfs;  Blumeria  (formerly  Erysiphe )  graminis  (powdery mildew) on cereals (e.g. on wheat or barley);  Botrytis cinerea  (teleomorph:  Botryotinia fuckeliana : grey mold) on fruits and berries (e.g. strawberries), vegetables (e.g. lettuce, carrots, celery and cabbages), rape, flowers, vines, forestry plants and wheat;  Drechslera  (syn.  Helminthosporium , teleomorph:  Pyrenophora ) spp. on corn, cereals, such as barley (e.g.  D. teres , net blotch) and wheat (e.g.  D. tritici - repentis : tan spot), rice and turf;  Esca  (dieback, apoplexy) on vines;  Erysiphe  spp. (powdery mildew) on sugar beets ( E. betae ), vegetables (e.g.  E. pisi ), such as cucurbits (e.g.  E. cichoracearum ), cabbages, rape (e.g.  E. cruciferarum );  Fusarium  (teleomorph:  Gibberella ) spp. (wilt, root or stem rot) on various plants, such as  F. graminearum  or  F. culmorum  (root rot, scab or head blight) on cereals (e.g. wheat or barley),  F. oxysporum  on tomatoes,  F. solani  on soybeans and  F. verticillioides  on corn;  Gaeumannomyces graminis  (take-all) on cereals (e.g. wheat or barley) and corn;  Gibberella  spp. on cereals (e.g.  G. zeae ) and rice (e.g.  G. fujikuroi : Bakanae disease);  Guignardia bidwellii  (black rot) on vines;  Microdochium  (syn.  Fusarium ) nivale (pink snow mold) on cereals (e.g. wheat or barley);  Monilinia  spp., e.g.  M. laxa, M. fructicola  and  M. fructigena  (bloom and twig blight, brown rot) on stone fruits and other rosaceous plants;  Mycosphaerella  spp. on cereals, bananas, soft fruits and ground nuts, such as e.g.  M. graminicola  (anamorph:  Septoria tritici, Septoria  blotch) on wheat or  M. fijiensis  (black Sigatoka disease) on bananas;  Peronospora  spp. (downy mildew) on cabbage (e.g.  P. brassicae ), rape (e.g.  P. parasitica ), onions (e.g.  P. destructor ), tobacco ( P. tabacina ) and soybeans (e.g.  P. manshurica );  Phakopsora pachyrhizi  and  P. meibomiae  (soybean rust) on soybeans;  Phytophthora  spp. (wilt, root, leaf, fruit and stem root) on various plants, such as paprika and cucurbits (e.g.  P. capsici ), soybeans (e.g.  P. megasperma , syn.  P. sojae ), potatoes and tomatoes (e.g.  P. infestans : late blight);  Plasmopara  spp., e.g.  P. viticola  (grapevine downy mildew) on vines;  Puccinia  spp. (rusts) on various plants, e.g.  P. triticina  (brown or leaf rust),  P. striiformis  (stripe or yellow rust),  P. hordei  (dwarf rust),  P. graminis  (stem or black rust) or  P. recondita  (brown or leaf rust) on cereals, such as e.g. wheat, barley or rye, and asparagus (e.g.  P. asparagi );  Pyrenophora  (anamorph:  Drechslera ) tritici-repentis (tan spot) on wheat or  P. teres  (net blotch) on barley;  Pyricularia  spp., e.g.  P. oryzae  (teleomorph:  Magnaporthe grisea , rice blast) on rice and  P. grisea  on turf and cereals;  Pythium  spp. (damping-off) on turf, rice, corn, wheat, cotton, rape, sunflowers, soybeans, sugar beets, vegetables and various other plants (e.g.  P. ultimum  or  P. aphanidermatum );  Rhizoctonia  spp. on cotton, rice, potatoes, turf, corn, rape, potatoes, sugar beets, vegetables and various other plants, e.g.  R. solani  (root and stem rot) on soybeans,  R. solani  (sheath blight) on rice or  R. cerealis  ( Rhizoctonia  spring blight) on wheat or barley;  Rhynchosporium secalis  (scald) on barley, rye and triticale;  Septoria  spp. on various plants, e.g.  S. glycines  (brown spot) on soybeans,  S. tritici  ( Septoria  blotch) on wheat and  S . (syn.  Stagonospora )  nodorum  ( Stagonospora  blotch) on cereals;  Uncinula  (syn.  Erysiphe )  necator  (powdery mildew, anamorph:  Oidium tuckeri ) on vines;  Stagonospora  spp. on cereals, e.g.  S. nodorum  ( Stagonospora  blotch, teleomorph:  Leptosphaeria  [syn.  Phaeosphaeria] nodorum ) on wheat;  Venturia  spp. (scab) on apples (e.g.  V. inaequalis ) and pears. 
     The compounds I and compositions thereof, respectively, are also suitable for controlling harmful fungi in the protection of stored products or harvest and in the protection of materials. The term “protection of materials” is to be understood to denote the protection of technical and non-living materials, such as adhesives, glues, wood, paper and paperboard, textiles, leather, paint dispersions, plastics, coiling lubricants, fiber or fabrics, against the infestation and destruction by harmful microorganisms, such as fungi and bacteria. 
     The compounds I and compositions thereof, resepectively, may be used for improving the health of a plant. The invention also relates to a method for improving plant health by treating a plant, its propagation material and/or the locus where the plant is growing or is to grow with an effective amount of compounds I and compositions thereof, respectively. 
     The term “plant health” is to be understood to denote a condition of the plant and/or its products which is determined by several indicators alone or in combination with each other such as yield (e.g. increased biomass and/or increased content of valuable ingredients), plant vigor (e.g. improved plant growth and/or greener leaves (“greening effect”)), quality (e.g. improved content or composition of certain ingredients) and tolerance to abiotic and/or biotic stress. The above identified indicators for the health condition of a plant may be interdependent or may result from each other. 
     The compounds of formula I can be present in different crystal modifications whose biological activity may differ. They are likewise subject matter of the present invention. 
     The compounds I are employed as such or in form of compositions by treating the fungi or the plants, plant propagation materials, such as seeds, soil, surfaces, materials or rooms to be protected from fungal attack with a fungicidally effective amount of the active substances. The application can be carried out both before and after the infection of the plants, plant propagation materials, such as seeds, soil, surfaces, materials or rooms by the fungi. 
     The invention also relates to agrochemical compositions comprising a solvent or solid carrier and at least one compound I and to the use for controlling harmful fungi. 
     An agrochemical composition comprises a fungicidally effective amount of a compound I. The term “effective amount” denotes an amount of the composition or of the compounds I, which is sufficient for controlling harmful fungi on cultivated plants or in the protection of materials and which does not result in a substantial damage to the treated plants. Such an amount can vary in a broad range and is dependent on various factors, such as the fungal species to be controlled, the treated cultivated plant or material, the climatic conditions and the specific compound I used. 
     The compounds I, their N-oxides and salts can be converted into customary types of agrochemical compositions, e.g. solutions, emulsions, suspensions, dusts, powders, pastes and granules. The composition type depends on the particular intended purpose; in each case, it should ensure a fine and uniform distribution of the compound according to the invention. 
     Examples for composition types are suspensions (SC, OD, FS), emulsifiable concentrates (EC), emulsions (EW, EO, ES), pastes, pastilles, wettable powders or dusts (WP, SP, SS, WS, DP, DS) or granules (GR, FG, GG, MG), which can be water-soluble or wettable, as well as gel formulations for the treatment of plant propagation materials such as seeds (GF). 
     Usually the composition types (e.g. SC, OD, FS, EC, WG, SG, WP, SP, SS, WS, GF) are employed diluted. Composition types such as DP, DS, GR, FG, GG and MG are usually used undiluted. 
     The compositions are prepared in a known manner (cf. U.S. Pat. No. 3,060,084, EP-A 707 445 (for liquid concentrates), Browning: “Agglomeration”, Chemical Engineering, Dec. 4, 1967, 147-48, Perry&#39;s Chemical Engineer&#39;s Handbook, 4th Ed., McGraw-Hill, New York, 1963, S. 8-57 and ff. WO 91/13546, U.S. Pat. No. 4,172,714, U.S. Pat. No. 4,144,050, U.S. Pat. No. 3,920,442, U.S. Pat. No. 5,180,587, U.S. Pat. No. 5,232,701, U.S. Pat. No. 5,208,030, GB 2,095,558, U.S. Pat. No. 3,299,566, Klingman: Weed Control as a Science (J. Wiley &amp; Sons, New York, 1961), Hance et al.: Weed Control Handbook (8th Ed., Blackwell Scientific, Oxford, 1989) and Mollet, H. and Grubemann, A.: Formulation technology (Wiley VCH Verlag, Weinheim, 2001). 
     The agrochemical compositions may also comprise auxiliaries which are customary in agrochemical compositions. The auxiliaries used depend on the particular application form and active substance, respectively. 
     Examples for suitable auxiliaries are solvents, solid carriers, dispersants or emulsifiers (such as further solubilizers, protective colloids, surfactants and adhesion agents), organic and anorganic thickeners, bactericides, anti-freezing agents, anti-foaming agents, if appropriate colorants and tackifiers or binders (e.g. for seed treatment formulations). 
     Powders, materials for spreading and dusts can be prepared by mixing or concomitantly grinding the compounds I and, if appropriate, further active substances, with at least one solid carrier. 
     Granules, e.g. coated granules, impregnated granules and homogeneous granules, can be prepared by binding the active substances to solid carriers. 
     The agrochemical compositions generally comprise between 0.01 and 95%, preferably between 0.1 and 90%, most preferably between 0.5 and 90%, by weight of active substance. The active substances are employed in a purity of from 90% to 100%, preferably from 95% to 100% (according to NMR spectrum). 
     Water-soluble concentrates (LS), flowable concentrates (FS), powders for dry treatment (DS), water-dispersible powders for slurry treatment (WS), water-soluble powders (SS), emulsions (ES) emulsifiable concentrates (EC) and gels (GF) are usually employed for the purposes of treatment of plant propagation materials, particularly seeds. These compositions can be applied to plant propagation materials, particularly seeds, diluted or undiluted. The compositions in question give, after two-to-tenfold dilution, active substance concentrations of from 0.01 to 60% by weight, preferably from 0.1 to 40% by weight, in the ready-to-use preparations. 
     In a preferred embodiment, a suspension-type (FS) composition is used for seed treatment. Typcially, a FS composition may comprise 1-800 g/l of active substance, 1-200 g/l Surfactant, 0 to 200 g/l antifreezing agent, 0 to 400 g/l of binder, 0 to 200 g/l of a pigment and up to 1 liter of a solvent, preferably water. 
     Aqueous application forms can be prepared from emulsion concentrates, pastes or wettable powders (sprayable powders, oil dispersions) by adding water. To prepare emulsions, pastes or oil dispersions, the substances, as such or dissolved in an oil or solvent, can be homogenized in water by means of a wetter, tackifier, dispersant or emulsifier. Alternatively, it is possible to prepare concentrates composed of active substance, wetter, tackifier, dispersant or emulsifier and, if appropriate, solvent or oil, and such concentrates are suitable for dilution with water. 
     The active substance concentrations in the ready-to-use preparations can be varied within relatively wide ranges. In general, they are from 0.0001 to 10%, preferably from 0.001 to 1% by weight of active substance. 
     The active substances may also be used successfully in the ultra-low-volume process (ULV), it being possible to apply compositions comprising over 95% by weight of active substance, or even to apply the active substance without additives. 
     When employed in plant protection, the amounts of active substances applied are, depending on the kind of effect desired, from 0.001 to 2 kg per ha, preferably from 0.005 to 2 kg per ha, more preferably from 0.05 to 0.9 kg per ha, in particular from 0.1 to 0.75 kg per ha. 
     In treatment of plant propagation materials such as seeds, e.g. by dusting, coating or drenching seed, amounts of active substance of from 0.1 to 1000 g, preferably from 1 to 1000 g, more preferably from 1 to 100 g and most preferably from 5 to 100 g, per 100 kilogram of plant propagation material (preferably seed) are generally required. 
     When used in the protection of materials or stored products, the amount of active substance applied depends on the kind of application area and on the desired effect. Amounts customarily applied in the protection of materials are, e.g., 0.001 g to 2 kg, preferably 0.005 g to 1 kg, of active substance per cubic meter of treated material. 
     Various types of oils, wetters, adjuvants, herbicides, bactericides, other fungicides and/or pesticides may be added to the active substances or the compositions comprising them, if appropriate not until immediately prior to use (tank mix). These agents can be admixed with the compositions according to the invention in a weight ratio of 1:100 to 100:1, preferably 1:10 to 10:1. 
     The compositions according to the invention can, in the use form as fungicides, also be present together with other active substances, e.g. with herbicides, insecticides, growth regulators, fungicides or else with fertilizers, as pre-mix or, if appropriate, not until immeadiately prior to use (tank mix). 
     Mixing the compounds I or the compositions comprising them in the use form as fungicides with other fungicides results in many cases in an expansion of the fungicidal spectrum of activity being obtained or in a prevention of fungicide resistance development. Furthermore, in many cases, synergistic effects are obtained. 
     The following list of active substances, in conjunction with which the compounds according to the invention can be used, is intended to illustrate the possible combinations but does not limit them: 
     A) Strobilurins 
     
         
         
           
             azoxystrobin, dimoxystrobin, enestroburin, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, pyribencarb, trifloxystrobin, 2-(2-(6-(3-chloro-2-methyl-phenoxy)-5-fluoro-pyrimidin-4-yloxy)-phenyl)-2-methoxyimino-N-methyl-acetamide, 3-methoxy-2-(2-(N-(4-methoxy-phenyl)-cyclopropane-carboximidoylsulfanylmethyl)-phenyl)-acrylic acid methyl ester, methyl (2-chloro-5-[1-(3-methylbenzyloxyimino)ethyl]benzyl)carbamate and 2-(2-(3-(2,6-dichlorophenyl)-1-methyl-allylideneaminooxymethyl)-phenyl)-2-methoxyimino-N-methyl-acetamide; 
           
         
       
    
     B) Carboxamides 
     
         
         
           
             carboxanilides: benalaxyl, benalaxyl-M, benodanil, bixafen, boscalid, carboxin, fenfuram, fenhexamid, flutolanil, furametpyr, isopyrazam, isotianil, kiralaxyl, mepronil, metalaxyl, metalaxyl-M (mefenoxam), ofurace, oxadixyl, oxycarboxin, penthiopyrad, sedaxane, tecloftalam, thifluzamide, tiadinil, 2-amino-4-methyl-thiazole-5-carboxanilide, 2-chloro-N-(1,1,3-trimethyl-indan-4-yl)-nicotinamide, N-(3′,4′,5′-trifluorobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide, N-(4′-trifluoro-methylthiobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide, N-(2-(1,3-dimethyl-butyl)-phenyl)-1,3-dimethyl-5-fluoro-1H-pyrazole-4-carboxamide and N-(2-(1,3,3-trimethyl-butyl)-phenyl)-1,3-dimethyl-5-fluoro-1H-pyrazole-4-carboxamide; 
             carboxylic morpholides: dimethomorph, flumorph, pyrimorph; 
             benzoic acid amides: flumetover, fluopicolide, fluopyram, zoxamide, N-(3-Ethyl-3,5,5-trimethyl-cyclohexyl)-3-formylamino-2-hydroxy-benzamide; 
             other carboxamides: carpropamid, dicyclomet, mandiproamid, oxytetracyclin, silthiofarm and N-(6-methoxy-pyridin-3-yl)cyclopropanecarboxylic acid amide; 
           
         
       
    
     C) Azoles 
     
         
         
           
             triazoles: azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, diniconazole-M, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil, oxpoconazole, paclobutrazole, penconazole, propiconazole, prothioconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, uniconazole, 1-(4-chloro-phenyl)-2-([1,2,4]triazol-1-yl)-cycloheptanol; 
             imidazoles: cyazofamid, imazalil, pefurazoate, prochloraz, triflumizol; 
             benzimidazoles: benomyl, carbendazim, fuberidazole, thiabendazole; 
             others: ethaboxam, etridiazole, hymexazole and 2-(4-chloro-phenyl)-N-[4-(3,4-dimethoxy-phenyl)isoxazol-5-yl]-2-prop-2-ynyloxy-acetamide; 
           
         
       
    
     D) Heterocyclic Compounds 
     
         
         
           
             pyridines: fluazinam, pyrifenox, 3-[5-(4-chloro-phenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine, 3-[5-(4-methyl-phenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine, 2,3,5,6-tetra-chloro-4-methanesulfonyl-pyridine, 3,4,5-trichloropyridine-2,6-di-carbonitrile, N-(1-(5-bromo-3-chloro-pyridin-2-yl)-ethyl)-2,4-dichloro-nicotinamide, N-[(5-bromo-3-chloro-pyridin-2-yl)-methyl]-2,4-dichloro-nicotinamide; 
             pyrimidines: bupirimate, cyprodinil, diflumetorim, fenarimol, ferimzone, mepanipyrim, nitrapyrin, nuarimol, pyrimethanil; 
             piperazines: triforine; 
             pyrroles: fenpiclonil, fludioxonil; 
             morpholines: aldimorph, dodemorph, dodemorph-acetate, fenpropimorph, tridemorph; 
             piperidines: fenpropidin; 
             dicarboximides: fluoroimid, iprodione, procymidone, vinclozolin; 
             non-aromatic 5-membered heterocycles: famoxadone, fenamidone, flutianil, octhilinone, probenazole, 5-amino-2-isopropyl-3-oxo-4-ortho-tolyl-2,3-dihydro-pyrazole-1-carbothioic acid S-allyl ester; 
             others: acibenzolar-5-methyl, amisulbrom, anilazin, blasticidin-S, captafol, captan, chinomethionat, dazomet, debacarb, diclomezine, difenzoquat, difenzoquat-methylsulfate, fenoxanil, Folpet, oxolinic acid, piperalin, proquinazid, pyroquilon, quinoxyfen, triazoxide, tricyclazole, 2-butoxy-6-iodo-3-propylchromen-4-one, 5-chloro-1-(4,6-dimethoxy-pyrimidin-2-yl)-2-methyl-1H-benzoimidazole, 5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyrimidine and 5-ethyl-6-octyl-[1,2,4]triazolo[1,5-a]pyrimidine-7-ylamine; 
           
         
       
    
     E) Carbamates 
     
         
         
           
             thio- and dithiocarbamates: ferbam, mancozeb, maneb, metam, methasulphocarb, metiram, propineb, thiram, zineb, ziram; 
             carbamates: benthiavalicarb, diethofencarb, iprovalicarb, propamocarb, propamocarb hydrochlorid, valiphenal and N-(1-(1-(4-cyano-phenyl)ethanesulfonyl)-but-2-yl) carbamic acid-(4-fluorophenyl) ester; 
           
         
       
    
     F) Other Active Substances 
     
         
         
           
             guanidines: guanidine, dodine, dodine free base, guazatine, guazatine-acetate, iminoctadine, iminoctadine-triacetate, iminoctadine-tris(albesilate); 
             antibiotics: kasugamycin, kasugamycin hydrochloride-hydrate, streptomycin, polyoxine, validamycin A; 
             nitrophenyl derivates: binapacryl, dinobuton, dinocap, nitrthal-isopropyl, tecnazen, organometal compounds: fentin salts, such as fentin-acetate, fentin chloride or fentin hydroxide; 
             sulfur-containing heterocyclyl compounds: dithianon, isoprothiolane; 
             organophosphorus compounds: edifenphos, fosetyl, fosetyl-aluminum, iprobenfos, phosphorous acid and its salts, pyrazophos, tolciofos-methyl; 
             organochlorine compounds: chlorothalonil, dichiofluanid, dichlorophen, flusulfamide, hexachlorobenzene, pencycuron, pentachlorphenole and its salts, phthalide, quintozene, thiophanate-methyl, tolylfluanid, N-(4-chloro-2-nitro-phenyl)-N-ethyl-4-methylbenzenesulfonamide; 
             inorganic active substances: Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride, basic copper sulfate, sulfur; 
             others: biphenyl, bronopol, cyflufenamid, cymoxanil, diphenylamin, metrafenone, mildiomycin, oxin-copper, prohexadione-calcium, spiroxamine, tolylfluanid, N-(cyclopropylmethoxyimino-(6-difluoro-methoxy-2,3-difluoro-phenyl)-methyl)-2-phenyl acetamide, N′-(4-(4-chloro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methyl formamidine, N′-(4-(4-fluoro-3-trifluoromethyl-phenoxy)-2,5-dimethylphenyl)-N-ethyl-N-methyl formamidine, N′-(2-methyl-5-trifluoromethyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl formamidine, N′-(5-difluoromethyl-2-methyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl formamidine, 2-{1-[2-(5-methyl-3-trifluoromethyl-pyrazole-1-yl)-acetyl]-piperidin-4-yl}-thiazole-4-carboxylic acid methyl-(1,2,3,4-tetrahydro-naphthalen-1-yl)-amide, 2-{1-[2-(5-methyl-3-trifluoromethyl-pyrazole-1-yl)-acetyl]-piperidin-4-yl}-thiazole-4-carboxylic acid methyl-(R)-1,2,3,4-tetrahydro-naphthalen-1-yl-amide, acetic acid 6-tert.-butyl-8-fluoro-2,3-dimethyl-quinolin-4-yl ester and methoxy-acetic acid 6-tert-butyl-8-fluoro-2,3-dimethyl-quinolin-4-yl ester. 
           
         
       
    
     The present invention furthermore relates to agrochemical compositions comprising a mixture of at least one compound I (component 1) and at least one further active substance useful for plant protection, e.g. selected from the groups A) to I) (component 2), in particular one further fungicide, e.g. one or more fungicide from the groups A) to F), as described above, and if desired one suitable solvent or solid carrier. Those mixtures are of particular interest, since many of them at the same application rate show higher efficiencies against harmful fungi. By applying compounds I together with at least one active substance from groups A) to I) a synergistic effect can be obtained, i.e. more then simple addition of the individual effects is obtained (synergistic mixtures). 
     In binary mixtures, i.e. compositions according to the invention comprising one compound I (component 1) and one further active substance (component 2), e.g. one active substance from groups A) to I), the weight ratio of component 1 and component 2 generally depends from the properties of the active substances used, usually it is in the range of from 1:100 to 100:1, regularly in the range of from 1:50 to 50:1, preferably in the range of from 1:20 to 20:1, more preferably in the range of from 1:10 to 10:1 and in particular in the range of from 1:3 to 3:1. 
     In ternary mixtures, i.e. compositions according to the invention comprising one compound I (component 1) and a first further active substance (component 2) and a second further active substance (component 3), e.g. two active substances from groups A) to I), the weight ratio of component 1 and component 2 depends from the properties of the active substances used, preferably it is in the range of from 1:50 to 50:1 and particularly in the range of from 1:10 to 10:1, and the weight ratio of component 1 and component 3 preferably is in the range of from 1:50 to 50:1 and particularly in the range of from 1:10 to 10:1. 
     Preference is also given to mixtures comprising a compound I (component 1) and at least one active substance selected from the strobilurines of group A) (component 2) and particularly selected from azoxystrobin, dimoxystrobin, fluoxastrobin, kresoxim-methyl, orysastrobin, picoxystrobin, pyraclostrobin and trifloxystrobin. 
     Preference is also given to mixtures comprising a compound I (component 1) and at least one active substance selected from the carboxamides of group B) (component 2) and particularly selected from bixafen, boscalid, sedaxane, fenhexamid, metalaxyl, isopyrazam, mefenoxam, ofurace, dimethomorph, flumorph, fluopicolid (picobenzamid), zoxamide, carpropamid, mandipropamid and N-(3′,4′,5′-trifluorobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide. 
     Preference is given to mixtures comprising a compound of formula I (component 1) and at least one active substance selected from the azoles of group C) (component 2) and particularly selected from cyproconazole, difenoconazole, epoxiconazole, fluquinconazole, flusilazole, flutriafol, metconazole, myclobutanil, penconazole, propiconazole, prothioconazole, triadimefon, triadimenol, tebuconazole, tetraconazole, triticonazole, prochloraz, cyazofamid, benomyl, carbendazim and ethaboxam. 
     Preference is also given to mixtures comprising a compound I (component 1) and at least one active substance selected from the heterocyclic compounds of group D) (component 2) and particularly selected from fluazinam, cyprodinil, fenarimol, mepanipyrim, pyrimethanil, triforine, fludioxonil, dodemorph, fenpropimorph, tridemorph, fenpropidin, iprodione, vinclozolin, famoxadone, fenamidone, probenazole, proquinazid, acibenzolar-S-methyl, captafol, folpet, fenoxanil, quinoxyfen and 5-ethyl-6-octyl-[1,2,4]triazolo[1,5-a]pyrimidine-7-ylamine. 
     Preference is also given to mixtures comprising a compound I (component 1) and at least one active substance selected from the carbamates of group E) (component 2) and particularly selected from mancozeb, metiram, propineb, thiram, iprovalicarb, benthiavalicarb and propamocarb. 
     Preference is also given to mixtures comprising a compound I (component 1) and at least one active substance selected from the fungicides given in group F) (component 2) and particularly selected from dithianon, fentin salts, such as fentin acetate, fosetyl, fosetyl-aluminium, H 3 PO 3  and salts thereof, chiorthalonil, dichlofluanid, thiophanatmethyl, copper acetate, copper hydroxide, copper oxychloride, copper sulfate, sulfur, cymoxanil, metrafenone and spiroxamine. 
     The active substances referred to as component 2, their preparation and their activity against harmful fungi is known (cf.: http://www.alanwood.net/pesticides/); these substances are commercially available. The compounds described by IUPAC nomenclature, their preparation and their fungicidal activity are also known (cf. Can. J. Plant Sci. 48(6), 587-94, 1968; EP-A 141 317; EP-A 152 031; EP-A 226 917; EP-A 243 970; EP-A 256 503; EP-A 428 941; EP-A 532 022; EP-A 1 028 125; EP-A 1 035 122; EP-A 1 201 648; EP-A 1 122 244, JP 2002316902; DE 19650197; DE 10021412; DE 102005009458; U.S. Pat. No. 3,296,272; U.S. Pat. No. 3,325,503; WO 98/46608; WO 99/14187; WO 99/24413; WO 99/27783; WO 00/29404; WO 00/46148; WO 00/65913; WO 01/54501; WO 01/56358; WO 02/22583; WO 02/40431; WO 03/10149; WO 03/11853; WO 03/14103; WO 03/16286; WO 03/53145; WO 03/61388; WO 03/66609; WO 03/74491; WO 04/49804; WO 04/83193; WO 05/120234; WO 05/123689; WO 05/123690; WO 05/63721; WO 05/87772; WO 05/87773; WO 06/15866; WO 06/87325; WO 06/87343; WO 07/82098; WO 07/90624). 
     The mixtures of active substances can be prepared as compositions comprising besides the active ingredients at least one inert ingredient by usual means, e.g. by the means given for the compositions of compounds I. Concerning usual ingredients of such compositions reference is made to the explanations given for the compositions containing compounds I. The mixtures of active substances according to the present invention are suitable as fungicides, as are the compounds of formula I. 
    
    
     I. SYNTHESIS EXAMPLES 
     With due modification of the starting compounds, the procedures shown in the synthesis examples below were used to obtain further compounds I. The resulting compounds, together with physical data, are listed in Table I below. 
     Example 1 
     Preparation of 4′-fluoro-biphenyl-4-sulfonic acid (2-dimethylamino-oxazolo[4,5-b]pyridin-7-ylmethyl)-amide 
     a) Preparation of dimethyl-oxazolo[4,5-b]pyridin-2-yl-amine 
     To a solution of 2-amino-3-hydroxypyridine (10 g) in pyridine (90 mL) were added catalytic amounts of DMAP (ca. 10 mol %), followed by slow addition of dimethylcarbamoylchloride (11.7 g) and the mixture was stirred at reflux for 2 days. The reaction was quenched by the slow addition of water (caution: exotherm), followed by DCM. The layers were separated and the aqueous phase was extracted with DCM (2×250 mL). The combined organic extracts were washed with water (1×100 mL) and the volatiles were removed in vacuo. The crude product was chromatographed to afford the desired product (1.46 g, 9.9%) as a light brown solid. 
     b) Preparation of 2-dimethylamino-oxazolo[4,5-b]pyridine-7-carbaldehyde 
     A solution of the preceding intermediate (1.45 g) in THF (50 mL) was cooled to about −70° C. and tert-butyl lithium (1.7 M in pentane) was slowly added. Stirring was continued at this temperature for an additional 30 min, followed by the addition of DMF (0.8 g) and stirring was continued for further 45 min at −70° C. The reaction mixture was allowed to warm up to room temperature and stirred overnight. Methanol (5 mL) was added and the mixture was stirred for 5 min. The reaction mixture was concentrated under reduced pressure and the residue was taken up in water and DCM. The layers were separated and the aqueous phase was extracted with DCM (2×100 mL). The combined organic extracts were washed with water (1×50 mL) and the volatiles were removed in vacuo. Purification using flash chromatography yielded the desired aldehyde (0.46 g, 27%) as a light yellow solid. 
     c) Preparation of 4′-fluoro-biphenyl-4-sulfonamide 
     To a solution of 4′-fluoro[1,1′-biphenyl]-4-sulfonyl chloride (2 g) in dioxane (20 mL) was added 25% aqueous ammonia and the mixture was stirred at ambient temperature for about 1 h. Sunbsequently, water and pentane were added, followed by solid NaCl and stirring continued for further 30 min. During this time a precipitate was formed which was collected by filtration and washed with pentane and water before drying to furnish to desired product (1.34 g, 72%) as a white solid. 
     d) Preparation of 4′-fluoro-biphenyl-4-sulfonic acid (2-dimethylamino-oxazolo[4,5-b]-pyridin-7-ylmethyl)-amide 
     To a solution of the preceding aldehyde intermediate (70 mg, see step b)) in toluene (5 mL) was added the preceding primary sulfonamide (119 mg, see step c)) and the resulting mixture was heated at reflux for 10 h. Upon cooling to 0° C. sudium triacetoxyborohydride (85 mg) was added and stirring was continued at 0° C. for further 2 h. The reaction mixture was subsequently allowed to warm up to room temperature and stirring continued overnight. The mixture was diluted with MTBE and quenched with water. After stirring for an additional 10 min, the phases were separated and the aqueous phase was extracted with MTBE (3×20 mL). The combined organic extracts were washed with water (2×10 mL) and dried over sodium sulfate. The volatiles were removed in vacuo and purification using flash chromatography yielded the desired sulfonic acid amide (50 mg, 32%) as a light yellow solid. 
     
       
         
           
               
             
               
                 Table I 
               
             
            
               
                   
               
               
                 Compounds of formula I.A to I.K. 
               
            
           
           
               
               
               
               
               
               
               
               
               
               
            
               
                 No. 
                 
                   
                     
                     
                         
                         
                     
                   
                 
                 A 
                 form. 
                 R c1   
                 R c2   
                 R c3   
                 R c4   
                 R c5   
                 Physical data* 
               
               
                   
               
            
           
           
               
               
               
               
               
               
               
               
               
               
            
               
                 1 
                 1H-pyrrolo[2,3-b]py- 
                 A-1 
                 I.A 
                 H 
                 H 
                 Cl 
                 H 
                 H 
                 191° C. 
               
               
                   
                 ridin-4-ylmethyl 
                   
                   
                   
                   
                   
                   
                   
                   
               
               
                 2 
                 1,3-dimethyl-1H-pyr- 
                 A-1 
                 I.B 
                 H 
                 H 
                 Cl 
                 H 
                 H 
                 190-194° C. 
               
               
                   
                 azolo[3,4-b]pyridin- 
                   
                   
                   
                   
                   
                   
                   
                   
               
               
                   
                 4-ylmethyl 
                   
                   
                   
                   
                   
                   
                   
                   
               
               
                 3 
                 1,3-dimethyl-1H-pyr- 
                 A-1 
                 I.B 
                 CF 3   
                 H 
                 CF 3   
                 H 
                 H 
                 118° C. 
               
               
                   
                 azolo[3,4-b]pyridin- 
                   
                   
                   
                   
                   
                   
                   
                   
               
               
                   
                 4-ylmethyl 
                   
                   
                   
                   
                   
                   
                   
                   
               
               
                 4 
                 1H-pyrrolo[2,3-b]py- 
                 A-5 
                 I.B 
                 H 
                 H 
                 Cl 
                 H 
                 H 
                 214° C. 
               
               
                   
                 ridin-4-ylmethyl 
                   
                   
                   
                   
                   
                   
                   
                   
               
               
                 5 
                 1-methyl-1H-pyrro- 
                 A-1 
                 I.B 
                 Cl 
                 H 
                 Cl 
                 H 
                 H 
                 174-175° C. 
               
               
                   
                 lo[2,3-b]pyridin- 
                   
                   
                   
                   
                   
                   
                   
                   
               
               
                   
                 4-ylmethyl 
                   
                   
                   
                   
                   
                   
                   
                   
               
               
                 6 
                 2,3-dihydro-1 H-pyr- 
                 A-1 
                 I.B 
                 H 
                 H 
                 Cl 
                 H 
                 H 
                 199° C. 
               
               
                   
                 rolo[2,3-b]pyridin- 
                   
                   
                   
                   
                   
                   
                   
                   
               
               
                   
                 4-ylmethyl 
                   
                   
                   
                   
                   
                   
                   
                   
               
               
                 7 
                 1-methyl-1H-pyrro- 
                 A-1 
                 I.B 
                 CF 3   
                 H 
                 CF 3   
                 H 
                 H 
                 199-200° C. 
               
               
                   
                 lo[2,3-b]pyridin- 
                   
                   
                   
                   
                   
                   
                   
                   
               
               
                   
                 4-ylmethyl 
                   
                   
                   
                   
                   
                   
                   
                   
               
               
                 8 
                 1,3-dimethyl-1H-pyr- 
                 A-1 
                 I.B 
                 H 
                 H 
                 H 
                 H 
                 H 
                 146-153° C. 
               
               
                   
                 azolo[3,4-b]pyridin- 
                   
                   
                   
                   
                   
                   
                   
                   
               
               
                   
                 4-ylmethyl 
                   
                   
                   
                   
                   
                   
                   
                   
               
               
                 9 
                 1,3-dimethyl-1H-pyr- 
                 A-1 
                 I.B 
                 H 
                 H 
                 F 
                 H 
                 H 
                 188-191° C. 
               
               
                   
                 azolo[3,4-b]pyridin- 
                   
                   
                   
                   
                   
                   
                   
                   
               
               
                   
                 4-ylmethyl 
                   
                   
                   
                   
                   
                   
                   
                   
               
               
                 10 
                 1H-pyrrolo[2,3-b]py- 
                 A-1 
                 I.B 
                 H 
                 H 
                 Cl 
                 H 
                 H 
                 251° C. 
               
               
                   
                 ridin-4-ylmethyl 
                   
                   
                   
                   
                   
                   
                   
                   
               
               
                 11 
                 [1,5]naphthyridin- 
                 A-1 
                 I.B 
                 Cl 
                 H 
                 Cl 
                 H 
                 H 
                 138-139° C. 
               
               
                   
                 4-ylmethyl 
                   
                   
                   
                   
                   
                   
                   
                   
               
               
                 12 
                 [1,5]naphthyridin- 
                 A-1 
                 I.B 
                 CF 3   
                 H 
                 CF 3   
                 H 
                 H 
                 155-156° C. 
               
               
                   
                 4-ylmethyl 
                   
                   
                   
                   
                   
                   
                   
                   
               
               
                 13 
                 2-dimethylamino- 
                 A-1 
                 I.B 
                 H 
                 H 
                 F 
                 H 
                 H 
                 244-246° C. 
               
               
                   
                 oxazolo[4,5-b]pyri- 
                   
                   
                   
                   
                   
                   
                   
                   
               
               
                   
                 din-7-ylmethyl 
                   
                   
                   
                   
                   
                   
                   
                   
               
               
                 14 
                 2-dimethylamino- 
                 A-1 
                 I.A 
                 H 
                 H 
                 F 
                 H 
                 H 
                 195-196° C. 
               
               
                   
                 oxazolo[4,5-b]pyri- 
                   
                   
                   
                   
                   
                   
                   
                   
               
               
                   
                 din-7-ylmethyl 
                   
                   
                   
                   
                   
                   
                   
                   
               
               
                 15 
                 thieno[3,2-b]pyridin- 
                 A-1 
                 I.B 
                 CF 3   
                 H 
                 CF 3   
                 H 
                 H 
                 194° C. 
               
               
                   
                 7-ylmethyl 
               
               
                   
               
               
                 *Physical data: m.p. [° C.]; HPLC/MS R t  [min], M + H + . For A, the definition is selected from A-1 to A-106 as defined earlier herein. For formula (form.), the number of the respective formula selected from I.A to I.K as defined earlier herein is given. 
               
               
                 HPLC column: RP-18 column (Chromolith Speed ROD from Merck KgaA, Germany), 50 mm × 4.6 mm; Eluent: acetonitrile + 0.1% trifluoroacetic acid (TFA)/water + 0.1% TFA (gradient from 5:95 to 95:5 in 5 min at 40° C., flow of 1.8 ml/min). MS: Quadrupol Elektrospray Ionisation, 80 V (positive mode). 
               
            
           
         
       
     
     II. EXAMPLES OF THE ACTION AGAINST HARMFUL FUNGI 
     The fungicidal action of the compounds of the formula I was demonstrated by the following experiments: 
     A) Microtiter Tests 
     The active substances were formulated separately as a stock solution in DMSO at a concentration of 10 000 ppm. 
     The measured parameters were compared to the growth of the active substance-free control variant (=100%) and the fungus- and active substance-free blank value to determine the relative growth in % of the pathogens in the individual active substances. 
     Use Example 1 
     Activity Against the Late Blight Pathogen  Phytophthora infestans  in the Microtiter Test 
     The stock solution was pipetted into a microtiter plate (MTP) and diluted to the stated active substance concentration using water. An zoospore suspension of  Phytophthora infestans  in a pea juice-based aqueous nutrient medium for fungi was then added. The plates were placed in a water vapor-saturated chamber at temperatures of 18° C. Using an absorption photometer, the MTPs were measured at 405 nm on day 7 after the inoculation. 
     Use Example 2 
     Activity Against  Pyricularia oryzae  in the Microtiterplate Test 
     The stock solutions were mixed according to the ratio, pipetted onto a micro titer plate (MTP) and diluted with water to the stated concentrations. A spore suspension of  Pyricularia oryzae  in a malt-based aqueous medium solution was then added. The plates were placed in a water vapor-saturated chamber at a temperature of 18° C. Using an absorption photometer, the MTPs were measured at 405 nm 7 days after the inoculation. 
     In this test, the samples which had been treated with 125 ppm of the active compound from examples 11 and 12, respectively, showed up to at most 10% relative growth of the pathogen. 
     B. Glasshouse Trials 
     The spray solutions were prepared in several steps: 
     The stock solution were prepared: a mixture of acetone and/or DMSO and the wetting agent/emulsifier Wettol EM 31, which is based on ethoxylated alkylphenoles, in a relation (volume) solvent-emulsifier of 99 to 1 was added to 25 mg of the compound to give a total of 10 ml. Water was then added to total volume of 100 ml. This stock solution was diluted with the described solvent-emulsifier-water mixture to the given concentration. 
     Use Example 3 
     Control of Late Blight on Tomatoes Caused by  Phytophthora infestans    
     Young seedlings of tomato plants were grown in pots. These plants were sprayed to run-off with an aqueous suspension, containing the concentration of active ingredient or their mixture mentioned in the table below. The next day, the treated plants were inoculated with an aqueous suspension of sporangia of  Phytophthora infestans . After inoculation, the trial plants were immediately transferred to a humid chamber. After 6 days at 18 to 20° C. and a relative humidity close to 100% the extent of fungal attack on the leaves was visually assessed as % diseased leaf area. 
     In this test, the plants which had been treated with 250 ppm of the active compound from examples 6, 8 and 9, respectively, showed an infection of less than or equal to 15% whereas the untreated plants were 90% infected. 
     Use Example 4 
     Curative Control of Soybean Rust on Soy Beans Caused by  Phakopsora pachyrhizi    
     Leaves of pot-grown soy bean seedlings were inoculated with spores of  Phakopsora pachyrhizi . To ensure the success of the artificial inoculation, the plants were transferred to a humid chamber with a relative humidity of about 95% and 23 to 27° C. for 24 h. The next day the plants were cultivated for 2 days in a greenhouse chamber at 23 to 27° C. and a relative humidity between 60 and 80%. Then the plants were sprayed to run-off with the prepared stock solutions. The plants were allowed to air-dry. Then the trial plants were cultivated again for 12 days in a greenhouse chamber at 23-27° C. and a relative humidity between 60 and 80%. The extent of fungal attack on the leaves was visually assessed as % diseased leaf area. 
     In this test, the plants which had been treated with 250 ppm of the active compound from example 9 showed an infection of less than or equal to 15% whereas the untreated plants were 90% infected.